Upload
others
View
5
Download
0
Embed Size (px)
Citation preview
Sterile API Pvt Ltd
[CIN: U 17121 DL 2007 PTC 168198]
Registered Office: 1705, 4th Floor, Onkar Bhawan, Bhagirath Palace,
Chandni Chowk, Delh-110 006 E-mail: [email protected]
Meeting of Un-Secured Creditors of Sterile API Pvt Ltd scheduled to be held under the supervision of the Hon'ble National Company Law
Tribunal
Day Saturday
Date 28th April, 2018
Time 10.30 A.M.
Venue Hotel City Park, KP Block, Gopal Mandir Road, Pitampura, New Delhi-
110 088
List of Documents
Sl. No.
Contents
1. Notice of Meeting of Un-Secured Creditors of Sterile API Pvt Ltd
2. Explanatory Statement under sections 230 & 232 of the Companies Act, 2013 and the Companies (Compromises, Arrangements and Amalgamations) Rules, 2016, and other applicable provisions, if any
3. Scheme of Amalgamation of Sterile API Pvt Ltd, Bluestar Dealers Pvt
Ltd, Sach Technology Pvt Ltd and Avenue Gems & Jewels Pvt Ltd with Sterile India Pvt Ltd, under sections 230 & 232 of the Companies Act, 2013, and other applicable provisions, if any
4. Copy of the Report on Valuation of Shares & Share Exchange Ratio of M/s Soni Chatrath & Co., Chartered Accountants
5. A copy each of the un-audited Financial Statements (provisional) of the Transferor Companies and the Transferee Company for the period
ended 31st July, 2017 and 31st December, 2017
6. Proxy Form
7. Attendance Slip
Sd/-
NPS Chawla, Advocate Chairperson for the meeting of
Un-Secured Creditors of Sterile API Pvt Ltd
Through
Place: New Delhi Date: 21st March, 2018
Sd/- Rajeev K Goel, Advocate
For Rajeev Goel & Associates
Counsel for the Applicants 785, Pocket-E, Mayur Vihar II
NH-24, Delhi 110 091 Mobile: 93124 09354
e-mail: [email protected]
BEFORE THE NATIONAL COMPANY LAW TRIBUNAL
NEW DELHI BENCH, NEW DELHI
(ORIGINAL JURISDICTION)
COMPANY APPLICATION NO. CA (CAA) 22 (ND) OF 2018
IN THE MATTER OF THE COMPANIES ACT, 2013 (18 OF 2013)
SECTIONS 230 & 232
AND
IN THE MATTER OF SCHEME OF AMALGAMATION
AND
IN THE MATTER OF
STERILE API PVT LTD APPLICANT/ TRANSFEROR COMPANY NO. 1
BLUESTAR DEALERS PVT LTD
APPLICANT/ TRANSFEROR COMPANY NO. 2
SACH TECHNOLOGY PVT LTD
APPLICANT/ TRANSFEROR COMPANY NO. 3
AVENUE GEMS & JEWELS PVT LTD APPLICANT/ TRANSFEROR COMPANY NO. 4
AND
STERILE INDIA PVT LTD APPLICANT/TRANSFEREE COMPANY
NOTICE CONVENING MEETING
To The Un-secured Creditors of
Sterile API Pvt Ltd
Take Notice that the Hon'ble National Company Law Tribunal, New Delhi Bench, New Delhi vide its Order dated 13th March, 2018, inter alia, directed for convening of a meeting of Un-secured Creditors of Sterile API Pvt Ltd (the
Transferor Company No. 1) for the purpose of considering and, if thought fit, approving, with or without modification(s), the proposed Scheme of
Amalgamation of Sterile API Pvt Ltd, Bluestar Dealers Pvt Ltd, Sach Technology Pvt Ltd and Avenue Gems & Jewels Pvt Ltd with Sterile India Pvt Ltd. In the said meeting the following Special Business will be transacted.
To consider and, if thought fit, to pass, with or without modification(s), the following resolution with specific majority as provided under sections 230 & 232
of the Companies Act, 2013, and other applicable provisions, if any:
“Resolved that pursuant to the provisions of sections 230 & 232 of the
Companies Act, 2013, the Companies (Compromises, Arrangements and Amalgamations) Rules, 2016, the National Company Law Tribunal Rules,
2016, and other applicable provisions, if any, and subject to the approval of the Hon'ble National Company Law Tribunal, New Delhi Bench, New Delhi and other competent authorities, if any, the proposed Amalgamation of Sterile
API Pvt Ltd, Bluestar Dealers Pvt Ltd, Sach Technology Pvt Ltd and Avenue Gems & Jewels Pvt Ltd (the Transferor Companies No. 1 to 4, respectively)
with Sterile India Pvt Ltd (the Transferee Company) be and is hereby approved.
Resolved further that the Report on Valuation of Shares & Share Exchange Ratio of the independent valuer-M/s Soni Chatrath & Co., Chartered
Accountants, New Delhi, as placed before the meeting, be and is hereby received, considered and taken on record. The share exchange ratio as recommended by the independent valuer for the proposed amalgamation,
being fair and reasonable to the Shareholders of all the Companies, be and is hereby considered, accepted and approved.
Resolved further that the salient features/terms and conditions of the amalgamation as set out in the draft Scheme of Amalgamation placed before
the meeting, which, inter-alia, include the following:
i. All assets and liabilities including Income Tax and all other statutory liabilities, if any, of the Transferor Companies will be transferred to and
vest in the Transferee Company.
ii. All the employees of the Transferor Companies in service on the Effective
Date, if any, shall become the employees of the Transferee Company on and from such date without any break or interruption in service and upon
terms and conditions not less favorable than those subsisting in the concerned Transferor Company on the said date.
iii. Appointed Date for Amalgamation will be 1st April, 2017, or such other date, as the Hon'ble National Company Law Tribunal or any other
competent authority may approve.
iv. Share Exchange Ratio for the Scheme will be as follows:
a. The Transferee Company will issue 1 (one) Equity Share of ₹100
each, credited as fully paid up, for every 27 (twenty-seven) Equity Shares of ₹10 each held in the Transferor Company No. 1-Sterile API
Pvt Ltd.
b. The Transferee Company will issue 5 (five) Equity Shares of ₹100
each, credited as fully paid up, for every 4 (four) Equity Shares of ₹10 each held in the Transferor Company No. 2-Bluestar Dealers Pvt
Ltd.
c. The Transferee Company will issue 1 (one) Equity Share of ₹100
each, credited as fully paid up, for every 72 (seventy-two) Equity Shares of ₹10 each held in the Transferor Company No. 3-Sach
Technology Pvt Ltd.
d. The Transferee Company will issue 1 (one) Equity Share of ₹100
each, credited as fully paid up, for every 104 (one hundred four) Equity Shares of ₹10 each held in the Transferor Company No. 4-
Avenue Gems & Jewels Pvt Ltd.
be and are hereby approved in specific.
Resolved further that subject to the approval of the Hon'ble National Company Law Tribunal and other competent authorities, if any, the Scheme of Amalgamation of Sterile API Pvt Ltd, Bluestar Dealers Pvt Ltd, Sach
Technology Pvt Ltd and Avenue Gems & Jewels Pvt Ltd with Sterile India Pvt Ltd, as placed in the meeting, be and is hereby approved.
Resolved further that the Board of Directors of the Company be and is hereby authorized to agree to such conditions or modifications (including the
Share Exchange Ratio and the Appointed Date) that may be imposed, required or suggested by the Hon'ble National Company Law Tribunal, New
Delhi Bench, New Delhi or any other authorities or that may otherwise be deemed fit or proper by the Board and to do all other acts, deeds or things which may be ancillary or incidental to the above mentioned matter or which
may otherwise be required for the aforesaid Scheme of Amalgamation.”
Take Further Notice that in pursuance of the said order, a meeting of the Un-secured Creditors of Sterile API Pvt Ltd is scheduled to be held on Saturday, 28th April, 2018, at 10.30 a.m. at Hotel City Park, KP Block,
Gopal Mandir Road, Pitampura, New Delhi-110 088, when you are requested to attend.
Take Further Notice that you may attend and vote at the said meeting in person or by proxy, provided that a proxy in the prescribed form, duly signed
by you, is deposited at the registered office of the Company as mentioned above not later than 48 hours before the time fixed for the meeting.
The Hon’ble Tribunal has appointed Mr NPS Chawla, Advocate, as the Chairperson, failing him Mr Kunal Sachdeva, Advocate, as the Alternate
Chairperson and Ms Reema Jain, Company Secretary in practice, as the Scrutinizer of the aforesaid meeting.
A copy each of the Explanatory Statement [under sections 230 & 232 of the Companies Act, 2013 and the Companies (Compromises, Arrangements and
Amalgamations) Rules, 2016, and other applicable provisions, if any], the proposed Scheme of Amalgamation, Form of Proxy, Attendance Slip and other
documents, if any, are enclosed.
The proposed Scheme of Amalgamation, if approved in the respective meetings of the Un-secured Creditors of Sterile API Pvt Ltd and Sterile India Pvt Ltd, will
be subject to the subsequent approval of the Hon’ble National Company Law Tribunal, New Delhi Bench, New Delhi.
Dated this 21st day of March, 2018
Sd/- NPS Chawla, Advocate
Chairperson for the meeting of Un-Secured Creditors of Sterile API Pvt Ltd
Through Sd/-
Rajeev K Goel, Advocate For Rajeev Goel & Associates
Counsel for the Applicants 785, Pocket-E, Mayur Vihar II
NH-24, Delhi 110 091
Mobile: 93124 09354 e-mail: [email protected]
Notes:
1. Only Un-secured Creditors of the Company may attend and vote (either in person or by proxy or by authorised representative as per Section 113 of
the Companies Act, 2013) at the meeting of Un-secured Creditors. The authorised representative of a body corporate which is an Un-secured Creditor of the Applicant Company may attend and vote at the Un-secured
Creditors’ meeting, provided a certified true copy of the resolution of the Board of Directors or other governing body of the body corporate is
deposited at the registered office of the Company not later than 48 hours before the time fixed for convening the meeting authorising such representative to attend and vote at the meeting.
2. An Un-secured Creditor of the Company, entitled to attend and vote at the
meeting, is entitled to appoint a proxy to attend and vote instead of himself and such proxy need not be a member/creditor of the Applicant Company. The Form of Proxy duly completed and signed should, however, be
deposited at the Registered Office of the Company not later than 48 hours before the time fixed for convening the meeting.
3. All the alterations, made in the Proxy Form, must be initialed.
4. All the persons attending the meeting are requested to hand over the
enclosed Attendance Slip, duly signed, for admission to the meeting hall.
5. All the persons attending the meeting are advised to bring original photo
identity proof for verification.
6. Notice of the meeting, Explanatory Statement, Proxy Form, Attendance Slip and other documents are also being placed on the website of the
Company: www.sterileindia.com. Encl.: As above
BEFORE THE NATIONAL COMPANY LAW TRIBUNAL
NEW DELHI BENCH, NEW DELHI
(ORIGINAL JURISDICTION)
COMPANY APPLICATION NO. CA (CAA) 22 (ND) OF 2018
IN THE MATTER OF THE COMPANIES ACT, 2013 (18 OF 2013)
SECTIONS 230 & 232
AND
IN THE MATTER OF SCHEME OF AMALGAMATION
AND
IN THE MATTER OF
STERILE API PVT LTD APPLICANT/ TRANSFEROR COMPANY NO. 1
BLUESTAR DEALERS PVT LTD
APPLICANT/ TRANSFEROR COMPANY NO. 2
SACH TECHNOLOGY PVT LTD
APPLICANT/ TRANSFEROR COMPANY NO. 3
AVENUE GEMS & JEWELS PVT LTD APPLICANT/ TRANSFEROR COMPANY NO. 4
AND
STERILE INDIA PVT LTD APPLICANT/TRANSFEREE COMPANY
Explanatory Statement
[Under sections 230 & 232 of the Companies Act, 2013 and the Companies (Compromises, Arrangements and Amalgamations) Rules, 2016, and other applicable provisions, if any]
1. Pursuant to the Order dated 13th March, 2018, passed by the Hon'ble
National Company Law Tribunal, New Delhi Bench, New Delhi, in the above referred joint Company Application, separate meetings of Un-secured Creditors of Sterile API Pvt Ltd (the Transferor Company No. 1)
and Sterile India Pvt Ltd (the Transferee Company) are scheduled to be convened on Saturday, 28th April, 2018, at 10.30 a.m. and 11.30
a.m., respectively, at Hotel City Park, KP Block, Gopal Mandir Road, Pitampura, New Delhi-110 088, for the purpose of considering and, if thought fit, approving, with or without modifications, the
proposed Scheme of Amalgamation of Sterile API Pvt Ltd, Bluestar Dealers Pvt Ltd, Sach Technology Pvt Ltd and Avenue Gems & Jewels
Pvt Ltd with Sterile India Pvt Ltd (hereinafter referred to as “this Scheme/the Scheme”).
2. A copy of the Scheme of Amalgamation setting out the terms and conditions of the proposed amalgamation, inter alia, providing for
Amalgamation of Sterile API Pvt Ltd, Bluestar Dealers Pvt Ltd, Sach Technology Pvt Ltd and Avenue Gems & Jewels Pvt Ltd with Sterile India Pvt Ltd; and other connected matters, is enclosed with this Explanatory
Statement.
3. Companies to the Scheme and their Background
3.1 The Applicant No. 1/the Transferor Company No. 1- Sterile API
Pvt Ltd:
a. The Transferor Company No. 1- Sterile API Pvt Ltd [Corporate Identification No. (CIN): U 17121 DL 2007 PTC 168198; Income Tax Permanent Account No. (PAN): AAOC S 4612 H] (hereinafter
referred to as “the Transferor Company No. 1/the Company”) was originally incorporated under the provisions of the
Companies Act, 1956, as a private limited company with the name and Style as ‘Shree Radhey Krishna Spinners Pvt Ltd’ vide Certificate of Incorporation dated 14th September, 2007 issued
by the Registrar of Companies, NCT of Delhi and Haryana, New Delhi. The name of the Company was changed to ‘Jubilant
Organics Pvt Ltd’ vide Fresh Certificate of Incorporation dated 22nd December, 2014 issued by the Registrar of Companies, New
Delhi. Subsequently, the name of the Company was changed to its present name ‘Sterile API Pvt Ltd’ vide Fresh Certificate of Incorporation dated 12th December, 2015 issued by the
Registrar of Companies, New Delhi.
b. Presently, the Registered Office of the Transferor Company No. 1 is situated at 1705, 4th Floor, Onkar Bhawan, Bhagirath Palace, Chandni Chowk, Delh-110 006; e-mail id: [email protected].
c. The detailed objects of the Transferor Company No. 1 are set
out in the Memorandum of Association and are briefly stated as below:
Main Objects:
1. To carry on the business of chemist, import, export, manufacturers and trading, including direct marketing, in drugs/pharmaceutical Organic & inorganic Compounds &
its derivatives of every nature like Ayurvedic, Unani, Homeopathic, Bio-chemic, Allopathic, pharmaceutical
preparations, medical equipments/ gadgets/ accessories and ancillaries and instruments, surgical/ scientific
apparatus and materials or all requisites for hospitals patients and Carbon & water for injection.
2. To manufacture, formulate, process, develop, refine,
import, export, wholesale and/or retail trade all kinds of
pharmaceuticals, antibiotics, drugs, medicines, biological, neutraceuticals, healthcare, ayurvedic and dietary
supplement products, medicinal\ preparations, vaccines, chemicals, chemical products, dry salters, mineral waters, wines, cordials, liquors, soups, broths and other
restoratives or foods and also to deal in medicinal goods such as surgical instruments, contraceptives,
photographic goods, oils, perfumes, cosmetics, patent medicines, soaps, artificial limbs, hospital requisites, proprietary medicines, veterinary medicines and tinctures
extracts and to carry on the business of vialling, bottling, repacking, processing of tablets, capsules, syrups,
injections, ointments, etc. and also to carry on the business of chemists, druggists, buyers, sellers, agents, distributors and stockiest of all kinds of pharmaceuticals
and Solvents, acid & different chemicals & gases and Allied Products.
3. To carry on in India or abroad business of importers,
merchants, general order suppliers, commission agents,
representatives, distributors, royalty owner, contractors, auctioneers, indent agents, passage agents, factors,
organizers, concessionaries, sale agents, sub agents in connection with the business as referred to in sub-clause
(1) above.
4. To promote, undertake and assist, planning, organization,
development, establishment, evaluation, maintenance, running and management of hospitals and healthcare
facilities, including dispensaries, neighborhood centers, ambulatory therapeutic and diagnostic clinics, acute care and referral hospitals, at primary, secondary and territory
levels for the practice of high quality medicine and for development and implementation of health and medical
care programmes for promotion and preservation of health and prevention, detection, diagnosis, treatment and rehabilitation of disease and disability in human
beings.
5. To enter into joint venture, partnerships or any diagnostic centre, healthcare and pharmaceuticals production, anti-tuberculosis medicine, production research and
production activities in India or abroad and engaged in wholesale, retail trade of medicines opening of drug
stores/chemist and realization of export/import transaction.
6. Processing of by-products of pharmaceutical Ingredients, distillation of solvents, processing of Acid & Chemicals,
(Research & Development of Pharmaceutical organic & inorganic compounds & its derivatives. Packing of LVP & SVP. Manufacturing of gelatin Capsule (soft & hard).
d. The Transferor Company No. 1 engaged in pharmaceutical
business, manufacturing of injectable sterile API and other related activities.
e. The present Authorised Share Capital of the Transferor Company No. 1 is ₹6,28,82,000 divided into 31,88,200 Equity Shares of
₹10 each aggregating to ₹3,18,82,000; and 3,10,000 Preference Shares of ₹100 each aggregating to ₹3,10,00,000. The present
Issued, Subscribed and Paid-up Share Capital of the Company is ₹3,18,81,800 divided into 31,88,180 Equity Shares of ₹10 each.
f. Detail of the present Board of Directors of the Transferor
Company No. 1 is given below:
Sl. No.
Name & Address DIN Designation
1. Mr Sanjeev Goel
78/12, Jain Sthanak, Ganaur Mandi, Sonipat-131
001, Haryana
00370189 Director
2. Mr Nalesh Gupta
187-A, Rishi Nagar, Rani Bagh, Delhi -110 034
05154036 Director
3.2 The Applicant No. 2/the Transferor Company No. 2- Bluestar Dealers Pvt Ltd:
a. The Transferor Company No. 2- Bluestar Dealers Pvt Ltd
[Corporate Identification No. (CIN): U 51909 DL 2009 PTC 267614; Income Tax Permanent Account No. (PAN): AADC B 9292 K] (hereinafter referred to as “the Transferor Company No.
2/the Company”) was incorporated under the provisions of the Companies Act, 1956, as a private limited company vide
Certificate of Incorporation dated 18th December, 2009 issued by the Registrar of Companies, West Bengal, Kolkata. Registered Office of the Company was shifted from the State of West Bengal
to the NCT of Delhi as approved by the Hon’ble Regional Director, Eastern Region, Ministry of Corporate Affairs, Kolkata vide Order
dated 31st March, 2014. The Registrar of Companies, Delhi & Haryana, New Delhi registered the aforesaid order and allotted a new CIN to the Company on 22nd March, 2014.
b. Presently, the Registered Office of the Transferor Company No.
2 is situated at 1705/5, 1st Floor, Bhagirath Palace, Delhi-110 006; e-mail id: [email protected].
c. The detailed objects of the Transferor Company No. 2 are set
out in the Memorandum of Association and are briefly stated as below:
Main Objects:
1. To carry on the business as distributors, agents, traders, merchants, contractors, brokers and otherwise deal in merchandise and articles of all kinds including clearing
agents, freight contractors, forwarding agents, licensing agents, general brokers, and to carry any kind of
commercial business. To carry on all of any of the business as buyers, sellers, suppliers, growers, processors, traders, merchants, indentures brokers, agents, assemblers,
stockiest of goods and commodities of any kind to work as commission agents, brokers, contractors, processors order
suppliers and dealing agents.
2. To sale, purchase, take on lease or acquire in any manner
whatsoever any apartment, house, flats, shops, offices, clubs, township, markets or other buildings and for these
purpose to purchase, take on lease or in exchange, hire or otherwise acquire and hold any land and prepare layout thereon, to use at or to let out of dispose off the same on
installment basis, rent basis or by outright sale or in any other mode of disposition, development and acquire and
deal in any and every kind of article and produces and materials used for building.
d. The Transferor Company No. 2 is engaged in trading activities,
working as commission agent and other related activities.
e. The present Authorised Share Capital of the Transferor Company No. 2 is ₹12,90,000 divided into 1,29,000 Equity Shares of ₹10
each. The present Issued, Subscribed and Paid-up Share Capital of the Company is ₹12,88,000 divided into 1,28,800 Equity
Shares of ₹10 each.
f. Detail of the present Board of Directors of the Transferor Company No. 2 is given below:
Sl. No.
Name & Address DIN Designation
1. Mr Prem Chand Goel B-37, Maharana Pratap
Enclave, Pitampura, Delhi -110 034
02822907 Director
2. Mr Vidya Sagar Aggarwal 187-A, Rishi Nagar, Rani Bagh, Delhi -110 034
06673575 Director
3.3 The Applicant No. 3/Transferor Company No. 3- Sach
Technology Pvt Ltd:
a. The Transferor Company No. 3- Sach Technology Pvt Ltd
[Corporate Identification No. (CIN): U 72900 DL 2009 PTC 267543; Income Tax Permanent Account No. (PAN): AANC S
2185 A] (hereinafter referred to as “the Transferor Company No. 3/the Company”) was incorporated under the provisions of the Companies Act, 1956, as a private limited company vide
Certificate of Incorporation dated 1st April, 2009 issued by the Registrar of Companies, NCT of Delhi and Haryana, New Delhi.
Registered Office of the Company was shifted from the State of Haryana to the NCT of Delhi as approved by the Hon’ble Regional Director, Northern Region, Ministry of Corporate Affairs, New
Delhi, vide Order dated 13th March, 2014. The Registrar of Companies, NCT of Delhi and Haryana, New Delhi registered the
aforesaid order of the Hon’ble Regional Director and allotted a new CIN to the Company on 7th April, 2014.
b. Presently the Registered Office of the Transferor Company No. 3 is situated at 1705/5, F/F, Bhagirath Palace, Delhi- 110 006; e-
mail id: [email protected]. c. The detailed objects of the Transferor Company No. 3 are set
out in the Memorandum of Association and are briefly stated as below:
Main Objects:
1. To carry on the business of Production and trading of all types of software i.e. non-customized and customized softwares, operating systems software, business & other
applications software, computer games software.
2. To carry on the business of Web-page designing.
3. To carry on the business of providing Software consultancy/
maintenance services.
4. To carry on in India or in any part to the world all kinds of manufacturing and trading of computer hardware and their by-products.
5. To carry on the business of providing Data processing
facilities.
6. To establish and run educational institutes of any type i.e.
schools, colleges, coaching centers, research institutes etc. subject to the approvals front the concerned govt.
departments for imparting computer education.
7. To purchase, sell, let on hire, repair, import, export, lease out or otherwise deal in any type of machinery which can
be used in computer field.
8. To conduct and/or maintain Scientific and Technical
Research and other Laboratories for the purpose of providing technical training, education, aid and advice
in any manner whatsoever in respect of any matter or problem connected with or incidental to computers related business.
9. To carry on in India or in any part of the world any kind of
activity relating to the computers field
Other Objects:
The Company has also adopted, inter alia, the following sub-clauses of the Other Objects Clause of its Memorandum of
Association:
2. To carry on business as importers and exports of goods or
merchandise of any description or to act as shippers, commission agents, advertising agents, traveling agents,
transport agents, forwarding and clearing agents, brokers, estate agents, hardware merchants.
33. To carry on the profession of consultants on management, employment, engineering industry and technical matters to
industry and business and to act as employment agents.
d. The Transferor Company No. 3 is engaged in trading activities, working as commission agent and other related activities.
e. The present Authorised Share Capital of the Transferor Company
No. 3 is ₹2,20,000 divided into 22,000 Equity Shares of ₹10
each. The present Issued, Subscribed and Paid-up Share Capital of the Company is ₹2,20,000 divided into 22,000 Equity Shares
of ₹10 each.
f. Detail of the present Board of Directors of the Transferor
Company No. 3 is given below:
Sl. No.
Name & Address DIN Designation
1. Mr Sanjeev Goel 78/12, Jain Sthanak,
Ganaur Mandi, Sonipat-131 001, Haryana
00370189 Director
2. Mr Vidya Sagar Aggarwal 187-A, Rishi Nagar, Rani
Bagh, Delhi -110 034
06673575 Director
3.4 The Applicant No. 4/the Transferor Company No. 4- Avenue Gems & Jewels Pvt Ltd:
a. The Transferor Company No. 4- Avenue Gems & Jewels Pvt Ltd
[Corporate Identification No. (CIN): U 52100 DL 2009 PTC
189939; Income Tax Permanent Account No. (PAN): AAHC A 6961 G] (hereinafter referred to as “the Transferor Company No.
4/the Company”) was incorporated under the provisions of the Companies Act, 1956, as a private limited company vide Certificate of Incorporation dated 1st May, 2009 issued by the
Registrar of Companies, NCT of Delhi and Haryana, New Delhi.
b. Presently, the Registered Office of the Transferor Company No. 4 is situated at 1705/5, 3rd Floor, Bhagirath Palace, Delhi-110 006; e-mail id: [email protected].
c. The detailed objects of the Transferor Company No. 4 are set
out in the Memorandum of Association and are briefly stated as below:
Main Objects:
1. To do business of manufacturing, trading, import, export, deals in gold, silver, platinum, diamond Jewellery & ornament, precious & semi-precious stones & birth stone,
jewellery, all types of chains, utensils of gold, silver, Diamond and all other precious metals, non-metals,
stones.
2. To cut, saw, clean, polish, sort drill, string and set up lapidary of diamonds, precious and semi-precious stones and to buy, sell, import, export and otherwise deal in rough
and polished diamonds, both industrial and gem quality and other precious and semi-precious gems, pearls and stones
and to carry on the business of testing, evaluation, appraisal and certification of gemstones, jewellery, minerals, curios, antiques and other works of art and to
work as certified valuers.
3. To trade & deal in, manage, purchase or otherwise acquire and sell, dispose of import, export, exchange, hold and deal in diamond, precious stone, gold and silver chains, bullion
and jewellery, pearls, coins, cups, medals, shields, curious articles of virtue, art and antiques and to deal, trade and
establish showroom, shop, for trading of goods for the above business and to carry on the business of Manufacturing, Trading & deal in all kind of Jewellery and
allied items, namely gold, silver and diamond.
4. To manufacture, repair, alter, Trade, Export, Import, wholesale, retail and otherwise deal in precious and non-precious metal and other jewellery, studded or otherwise
and all kinds of ornaments and to carry on the business as goldsmiths, silversmiths, jewellery, gem merchants,
importers, exporters and dealers in bullion gold, platinum, silver, precious metals, pearls, diamonds, gemstones minerals, painting, manuscripts, curious antiques, watches
and other things of art & craft.
Other Objects: The Company has also adopted, inter alia, the following sub-
clauses of the Other Objects Clause of its Memorandum of Association:
44. To carry on the business as importers, exporters, agents,
distributors, stockists, contractors, suppliers, dealers of
any kind and to act as manufacturers, representatives, agents, brokers, commission agents and merchant of
commodities, articles products and merchants of any kind or nature.
47. To carry on the business of and render & provide services as commission agents, selling & purchasing agents,
brokers, manufacturers, representatives or agents, stockists, distributors and agents to any person, firm or company.
d. The Transferor Company No. 4 is engaged in trading activities,
working as commission agent and other related activities.
e. The present Authorised Share Capital of the Transferor Company No. 4 is ₹1,00,000 divided into 10,000 Equity Shares of ₹10 each. The present Issued, Subscribed and Paid-up Share Capital
of the Company is ₹1,00,000 divided into 10,000 Equity Shares of ₹10 each.
f. Detail of the present Board of Directors of the Company is given
below:
Sl. No.
Name & Address DIN Designation
1. Mr Sanjeev Goel
78/12, Jain Sthanak, Ganaur Mandi, Sonipat-
131 001, Haryana
00370189 Director
2. Mrs Hema Gupta
187-A, Rishi Nagar, Rani Bagh, Delhi -110 034
06673595 Director
3.5 The Applicant No. 5/the Transferee Company- Sterile India Pvt Ltd:
a. The Transferee Company- Sterile India Pvt Ltd [Corporate Identification No. (CIN): U 74899 DL 1989 PTC 036517; Income
Tax Permanent Account No. (PAN): AAAC U 5331 M] (hereinafter referred to as “the Transferee Company/the Company”) was originally incorporated under the provisions of the Companies
Act, 1956, as a private limited company with the name and style as ‘Uniways Laboratories Pvt Ltd’ vide Certificate of
Incorporation dated 5th June, 1989 issued by the Registrar of Companies, NCT of Delhi and Haryana, New Delhi. Name of the Company was changed to ‘Sterile India Pvt Ltd’ vide Fresh
Certificate of Incorporation dated 7th July, 2010 issued by the Registrar of Companies, New Delhi.
b. Presently, the Registered Office of the Transferee Company is
situated at Unit No. 501, 5th Floor, Aggarwal Corporate Heights,
Plot No. A-7, Netaji Subhash Place, Pitampura, New Delhi-110 034; e-mail id: [email protected].
c. The detailed objects of the Transferee Company are set out in
the Memorandum of Association and are briefly stated as below:
Main Objects:
1. To manufacture, process, buy, sell and deal in all kinds of
medicines and medical preparations., drugs and
pharmaceutical products and surgical non-medicated and medicated products such as veterinary Drugs, cosmetics
and toilet medicated products, antibiotics, in mineral water, wine, cordials, liquors, broths and other restorative or food
products specially suitable and deemed to be suitable for invalids and convalescents, and deal in anatomical, orthopedic and surgical appliances of all kinds.
2. To carry on the business of chemicals, druggists and
chemical manufactures of clinical, pathological, and bacteriological, serological, biochemical of other medical examination, analysis and research and of vialling bottling,
packing and repacking and processing of capsules, syrups, tablets, injectable, arosols arid ointment.
3. To carry on the business of growing such plants, trees,
flowers, vegetables, aerosols and ointment related to
medical products to in para (1) above.
d. The Transferee Company is engaged in pharmaceutical business, manufacturing of injectable sterile API and other related
activities. e. The present Authorised Share Capital of the Transferee
Company is ₹25,00,00,000 divided into 25,00,000 Equity Shares of ₹100 each. The present Issued, Subscribed and Paid-up Share
Capital of the Company is ₹15,44,88,800 divided into 15,44,888 Equity Shares of ₹100 each.
f. Detail of the present Board of Directors of the Company is given
below:
Sl. No.
Name & Address DIN Designation
1. Mr Sanjeev Goel
78/12, Jain Sthanak, Ganaur Mandi, Sonipat-131 001, Haryana
00370189 Director
2. Mr Prem Chand Goel B-37, Maharana Pratap
Enclave, Pitampura, Delhi-110 034
02822907 Director
3. Ms Rajni Goel B-37, Maharana Pratap
Enclave, Pitampura, Delhi-110 034
06487666 Director
4. All the Transferor Companies and the Transferee Company are closely
held Group Companies under common shareholding, management and
control. The present Scheme of Amalgamation will not result in change in management of the Transferee Company.
5. Mr Sanjeev Goel and his family members are the present promoters of
all the Transferor and the Transferee Companies. Detail of the Core
Promoters is given below:
Sl. No.
Name, Address & DIN
1. Mr Sanjeev Goel 78/12, Jain Sthanak, Ganaur Mandi,
Sonipat-131 001, Haryana DIN: 00370189
6. The proposed Amalgamation of Sterile API Pvt Ltd, Bluestar Dealers Pvt
Ltd, Sach Technology Pvt Ltd and Avenue Gems & Jewels Pvt Ltd with
Sterile India Pvt Ltd, will be effected by the arrangement embodied in the Scheme of Amalgamation framed under sections 230 & 232 of the
Companies Act, 2013, the Companies (Compromises, Arrangements and Amalgamations) Rules, 2016, the National Company Law Tribunal Rules, 2016, and other applicable provisions, if any.
7. Rationale and Benefits of the Scheme:
The circumstances which justify and/or necessitate the proposed Scheme of Amalgamation of the Transferor Companies with the Transferee Company; and benefits of the proposed amalgamation as
perceived by the Board of Directors of these Companies, to the Shareholders and other stakeholders are, inter alia, as follows:
a. All the Transferor Companies and the Transferee Company are
closely held private limited Group Companies under common
shareholding, management and control. The proposed amalgamation of the Transferor Companies with the Transferee
Company would result in business synergy, consolidation of various Group Companies and pooling of their resources into a single entity.
b. The Transferor Company No. 1 and the Transferee Company are
engaged in similar business of manufacturing of injectable sterile API and other related activities. The Transferor Company No. 1 has very recently started business operations whereas the Transferee
Company is a well-established company in pharmaceutical business. The proposed amalgamation of the Transferor Company
No. 1 with the Transferee Company will provide business consolidation and various business synergy. The Transferor Companies No. 2 to 4 are engaged in trading activities, working as
commission agent and other related business. Since the financial resources of the Transferor Companies No. 2 to 4 are not fully
utilised in the trading business, the management has decided to consolidate their financial resources in the Transferee Company
and to focus on the pharmaceutical business only.
c. The proposed Scheme of Amalgamation would result in pooling of
physical, financial and human resource of these Companies for the most beneficial utilization of these factors in the combined entity.
Post Scheme, the Transferee Company will enjoy large financial and physical resources.
d. The proposed Scheme of Amalgamation will result in usual economies of a centralized and a large company including
elimination of duplicate work, reduction in overheads, better and more productive utilization of financial, human and other resource and enhancement of overall business efficiency. The proposed
Scheme will enable these Companies to combine their managerial and operating strength, to build a wider capital and financial base
and to promote and secure overall growth. e. The proposed amalgamation would enhance the shareholders’
value of the Transferor and the Transferee Companies.
f. The proposed Scheme of Amalgamation will have beneficial impact on the Transferor and the Transferee Companies, their
shareholders, employees and other stakeholders and all concerned. 8. Salient features of the Scheme of Amalgamation
8.1 The Scheme of Amalgamation, inter alia, provides as under:
i. All assets and liabilities including Income Tax and all other
statutory liabilities, if any, of the Transferor Companies will be
transferred to and vest in the Transferee Company.
ii. All the employees of the Transferor Companies in service on the Effective Date, if any, shall become the employees of the Transferee Company on and from such date without any break
or interruption in service and upon terms and conditions not less favorable than those subsisting in the concerned
Transferor Company on the said date.
iii. Appointed Date for Amalgamation will be 1st April, 2017 or such
other date, as the Hon'ble National Company Law Tribunal may approve.
iv. Share Exchange Ratio for the Amalgamation will be:
a. The Transferee Company will issue 1 (one) Equity Share of ₹100 each, credited as fully paid up, for every 27 (twenty-
seven) Equity Shares of ₹10 each held in the Transferor Company No. 1-Sterile API Pvt Ltd.
b. The Transferee Company will issue 5 (five) Equity Shares
of ₹100 each, credited as fully paid up, for every 4 (four) Equity Shares of ₹10 each held in the Transferor Company
No. 2-Bluestar Dealers Pvt Ltd.
c. The Transferee Company will issue 1 (one) Equity Share of ₹100 each, credited as fully paid up, for every 72 (seventy-
two) Equity Shares of ₹10 each held in the Transferor Company No. 3-Sach Technology Pvt Ltd.
d. The Transferee Company will issue 1 (one) Equity Share of
₹100 each, credited as fully paid up, for every 104 (one
hundred four) Equity Shares of ₹10 each held in the
Transferor Company No. 4- Avenue Gems & Jewels Pvt Ltd. 9. Extracts of the Scheme: Extracts of the selected clauses of the
Scheme are given below (points/clauses referred to in this part are of the Scheme of Amalgamation):
1.1 DEFINITIONS
In this Scheme, unless repugnant to the meaning or context thereof, the following expressions shall have the meaning as under:
a. “Act” means the Companies Act, 2013 (18 of 2013), the
Companies (Compromises, Arrangements and Amalgamations) Rules, 2016, the National Company Law Tribunal Rules, 2016, and any other Rules made there under, as the case may be
applicable; and the Companies Act, 1956 (1 of 1956), to the extent applicable, if any.
b. “Appointed Date” means commencement of business on 1st
April, 2017, or such other date as the Hon’ble National Company
Law Tribunal or any other competent authority may approve.
c. “Board of Directors” in relation to respective Transferor and Transferee Companies, as the case may be, shall, unless it is repugnant to the context or otherwise, include a Committee so
authorised by the Board, or any person authorised by the Board of Directors or such Committee.
d. “Effective Date” means the date on which the transfer and
vesting of the entire undertakings of these Transferor Companies
shall take effect, i.e., the date as specified in Clause 5 of this Scheme.
e. National Company Law Tribunal means appropriate Bench of
the Hon’ble National Company Law Tribunal constituted under the Companies Act, 2013, having territorial jurisdiction to sanction the present Scheme and other connected matters. The
National Company Law Tribunal has been referred to as the Tribunal/NCLT.
f. “Record Date” means the date to be fixed by the Board of
Directors of the Transferor Companies No. 1 to 4 and/or the
Transferee Company, with reference to which the eligibility of the shareholders of the Transferor Companies, for allotment of
shares in the Transferee Company pursuant to the Amalgamation in terms of this Scheme, shall be determined.
2. TRANSFER OF UNDERTAKING
a. With effect from the commencement of business on 1st April, 2017, i.e., the Appointed Date, subject to the provisions of the Scheme in relation to the modalities of transfer and vesting, the
undertaking and entire business and all immovable properties (including agricultural land, industrial land, residential land and
all other land and plots) where so ever situated and incapable of passing by physical delivery as also all other assets, capital work-in-progress, current assets, investments, deposits, bookings and
advances against residential and commercial plots and buildings, powers, authorities, awards, allotments, approvals and consents,
licenses, registrations, contracts, agreements, engagements, arrangement, rights, intellectual property rights, titles, interests, benefits and advantages of whatsoever nature belonging to or in
the ownership, power, possession, control of or vested in or granted in favour of or enjoyed by the Transferor Companies,
including but without being limited to, licenses granted by various government authorities for development of real estate projects, lease deeds, lease agreements, conveyance deed, registry, sale
agreements, purchase agreements, memorandum of understanding (MOU), joint development agreement, joint
venture agreements, award on successful bidding and/or auction, earnest money, deposits, approval/NOC given by various government and other competent authorities like environmental
clearances, approval for land use change (CLU), completion certificate, approval/NOC from fire department, approval/NOC
for water, electricity and sewerage, clearance by airport authority, approval/NOC from irrigation department, approval/NOC from forest department, approval/NOC from
underground water authority, approval/NOC from national highway authority, approval/NOC from high tension department,
all permits and licenses like liquor license, license to run restaurant, lift/escalator license, liberties, easements, advantages, benefits, privileges, leases, tenancy rights,
ownership, intellectual property rights including trademarks, brands, copy rights; quota rights, subsidies, capital subsidies,
concessions, exemptions, sales tax exemptions, concessions/ obligations under EPCG/Advance/DEPB licenses, approvals,
clearances, authorizations, certification, quality certification, utilities, electricity connections, electronics and computer link ups, services of all types, reserves, provisions, funds, benefit of
all agreements and all other interests arising to the Transferor Companies (hereinafter collectively referred to as “the said
assets”) shall, without any further act or deed or without payment of any duty or other charges, be transferred to and vested in the Transferee Company pursuant to the provisions of
Section 232 of the Act, for all the estate, right, title and interest of the Transferor Companies therein so as to become the
property of the Transferee Company but, subject to mortgages, charges and encumbrances, if any, then affecting the undertaking of the Transferor Companies without such charges
in any way extending to the undertaking of the Transferee Company.
b. Notwithstanding what is provided herein above, it is expressly
provided that in respect to such of the said assets as are movable
in nature or are otherwise capable of being transferred by physical delivery or by endorsement and delivery, the same shall
be so transferred, with effect from the appointed date, by the Transferor Companies to the Transferee Company after the Scheme is duly sanctioned and given effect to without requiring
any order of the Tribunal or any deed or instrument of conveyance for the same or without the payment of any duty or
other charges and shall become the property of the Transferee Company accordingly.
c. On and from the Appointed Date, all liabilities, provisions, duties and obligations including Income Tax and other statutory
liabilities, if any, of every kind, nature and description of the Transferor Companies whether provided for or not in the books of accounts of the Transferor Companies shall devolve and shall
stand transferred or be deemed to be transferred without any further act or deed, to the Transferee Company with effect from
the Appointed Date and shall be the liabilities, provisions, duties and obligations of the Transferee Company.
d. Similarly, on and from the Appointed Date, all the taxes and duties including advance tax, tax deducted at source, tax
collected at source, credit of MAT, self-assessment tax paid by or on behalf of the Transferor Companies immediately before the amalgamation shall become or be deemed to be the property of
the Transferee Company by virtue of the amalgamation. Upon the Scheme becoming effective, all the taxes paid (including
TDS) by the Transferor Companies from the appointed date, regardless of the period to which they relate, shall be deemed to have been paid for and on behalf of and to the credit of the
Transferee Company as effectively as if the Transferee Company had paid the same.
e. Without prejudice to the generality of the provisions contained in
aforesaid clauses, upon the Scheme becoming effective, requisite form(s) will be filed with the Registrar of Companies for creation, modification and/or satisfaction of charge(s), to the extent
required, to give effect to the provisions of this Scheme.
f. On the Scheme becoming effective, the Transferee Company shall be entitled to file/revise income tax returns, TDS returns and other statutory filings and returns, filed by it or by the
Transferor Companies, if required, and shall have the right to claim refunds, depreciation benefits, advance tax credits, etc., if
any.
g. All other assets & liabilities of the Transferor Companies, which
may not be specifically covered in the aforesaid clauses, shall also stand transferred to the Transferee Company with effect
from the Appointed Date.
5. OPERATIVE DATE OF THE SCHEME
a. This Scheme shall be effective from the last of the dates on which
certified copies of order of the Tribunal under Sections 230 and 232 of the Companies Act, 2013, are filed in the office(s) of the
concerned Registrar of Companies. Such date is called as the Effective Date.
b. Though this Scheme shall become effective from the Effective
Date, the provisions of this Scheme shall be applicable and come
into operation from the Appointed Date.
The aforesaid are the salient features/selected extracts of the Scheme. Please read the entire text of the Scheme to get acquainted with the complete provisions of the Scheme.
10. The proposed Scheme of Amalgamation is for the benefit of the
Transferor Companies No. 1 to 4 and of the Transferee Company and their respective shareholders. It is fair and reasonable and is not detrimental to the interest of the public.
11. Valuation exercise has been carried out to determine the share swap
ratio for the proposed Scheme of Amalgamation. M/s Soni Chatrath & Co., Chartered Accountants, New Delhi have prepared the Report on Valuation of Shares and Share Exchange Ratio. The Board of Directors
of the Transferor Companies No. 1 to 4 and of the Transferee Company based on the Report on Valuation of Shares & Share Exchange Ratio of
M/s Soni Chatrath & Co., Chartered Accountants and on the basis of their independent evaluation and judgment, came to the conclusion that the proposed exchange ratio is fair and reasonable to the Shareholders
of all the Companies.
A copy of the Report on Valuation of Shares & Share Exchange Ratio of M/s Soni Chatrath & Co., Chartered Accountants, giving basis of
valuation, valuation methodology and calculations, etc., is enclosed herewith.
12. The proposed Scheme of Amalgamation has been unanimously approved by the respective Board of Directors of the Transferor Companies No. 1
to 4 and the Transferee Company in the Board meetings held on 2nd December, 2017. None of the Directors voted against or abstained from voting on the resolution for approving the Scheme of Amalgamation in
the aforesaid meetings.
Further, the notices of the meetings of Un-secured Creditors of the Transferor Company No. 1 and the Transferee Company scheduled to be convened under the supervision of the Hon’ble National Company Law
Tribunal, the Explanatory Statement and other papers of these meetings have also been approved unanimously, by the respective Board of
Directors of the Transferor Companies No. 1 to 4 and of the Transferee Company in the Board meetings held on 15th March, 2018.
13. The present Scheme of Amalgamation, if approved by the respective meetings of the Un-secured Creditors of Sterile API Pvt Ltd and Sterile
India Pvt Ltd, will be subject to the subsequent approval of the Hon’ble National Company Law Tribunal, New Delhi Bench, New Delhi. No
specific approval is required to be obtained from any other government authority to the present Scheme of Amalgamation.
14. No proceedings for inspection, inquiry or investigation under the
provisions of the Companies Act, 2013, or under the provisions of the
Companies Act, 1956, are pending against the Transferor Companies No. 1 to 4 or of the Transferee Company.
15. Effect of the Scheme on the Promoters, Directors, Shareholders,
etc.:
15.1 Promoters and/or Directors of the Transferor Companies No. 1 to 4
and of the Transferee Company are deemed to be interested in the proposed Scheme of Amalgamation to the extent of their shareholding in, loan given to and remuneration drawn from, as the case may be,
the respective Companies. Similarly, Key Managerial Personnel (KMP) of the Transferor Companies No. 1 to 4 and of the Transferee
Company may also be deemed to be interested in the proposed Scheme to the extent of their shareholding in, loan given to and remuneration drawn from, as the case may be, the respective
Companies.
15.2 The proposed Scheme of Amalgamation would not have any effect on the material interest of the Promoters, Directors and Key Managerial Personnel of the Transferor Companies No. 1 to 4 and of the
Transferee Company different from that of the interest of other shareholders, creditors and employees of these Companies.
15.3 The proposed Scheme of Amalgamation does not envisage any
corporate debt restructuring. There is no proposal to restructure or vary the debt obligation of any of the Transferor Companies No. 1 to 4 or of the Transferee Company towards their respective creditors.
The proposed Scheme of Amalgamation will not adversely affect the rights of any of the creditors of the Transferor Companies and of the
Transferee Company in any manner whatsoever. 15.4 The proposed Scheme of Amalgamation will not have any adverse
effect on the secured creditors, un-secured creditors, employees and other stakeholders, if any, of the Transferor Companies or of the
Transferee Company. 16. A copy of the Scheme of Amalgamation is being filed with the concerned
Registrar of Companies.
17. A copy each of the un-audited Financial Statements (provisional) of the Transferor Companies No. 1 to 4 and of the Transferee Company for the period ended 31st July, 2017 and 31st December, 2017, are enclosed
herewith.
18. Total amount due to Un-secured Creditors (including statutory and other dues, etc.), as per the un-audited Financial Statements (provisional) for the period ended 31st July, 2017, is given below:
Sl.
No.
Total amount due to Un-secured
Creditors in
Amount ₹
1. Transferor Company No. 1- Sterile API Pvt Ltd 7,74,22,148
2. Transferor Company No. 2- Bluestar Dealers Pvt Ltd
1,53,000
3. Transferor Company No. 3- Sach Technology Pvt Ltd
43,500
4. Transferor Company No. 4- Avenue Gems & Jewels Pvt Ltd
64,000
5. Transferee Company- Sterile India Pvt Ltd 48,63,63,665
19. The following documents will be available for inspection or for obtaining
extracts from or for making or obtaining copies of, by the members and creditors at the registered office of the Transferor Companies and of the
Transferee Company on any working day from the date of this notice till the date of meeting between 11.00 A.M. to 4.00 P.M.:
a. The Memorandum and Articles of Association of the Transferor Companies No. 1 to 4 and of the Transferee Company.
b. The Audited Financial Statements of the Transferor Companies No.
1 to 4 and of the Transferee Company for the last 3 years ended 31st March, 2015, 31st March, 2016 and 31st March, 2017.
c. Un-audited Financial Statements (provisional) of the Transferor Companies No. 1 to 4 and of the Transferee Company for the period
ended 31st July, 2017 and 31st December, 2017.
d. Register of Particulars of Directors and KMP and their Shareholding,
of the Transferor Companies No. 1 to 4 and of the Transferee Company.
e. Copy of Order dated 13th March, 2018, passed by the Hon'ble
National Company Law Tribunal, New Delhi Bench, New Delhi, in
the joint Company Application No. CA (CAA) 22 (ND) of 2018 filed by the Transferor Companies No. 1 to 4 and of the Transferee
Company, in pursuance of which the aforesaid meetings are scheduled to be convened and other meetings have been dispensed with.
f. Paper Books and proceedings of the joint Company Application No.
CA (CAA) 22 (ND) of 2018.
g. Copy of the Report on Valuation of Shares & Share Exchange Ratio
of M/s Soni Chatrath & Co., Chartered Accountants.
h. Copy of the Certificate issued by the Statutory Auditors of the Transferor Companies and of the Transferee Company to the effect that the accounting treatment proposed in the Scheme of
Amalgamation is in conformity with the Accounting Standards prescribed under Section 133 of the Companies Act, 2013.
i. Copy of the proposed Scheme of Amalgamation.
20. A copy of the Scheme of Amalgamation, Explanatory Statement and Form of Proxy, Attendance Slip and other annexures may be obtained
free of charge on any working day (except Saturday) prior to the date of meeting, from the registered office of the Transferor Companies and of the Transferee Company or from the office of their Legal Counsel- Mr
Rajeev K Goel, Advocate, M/s Rajeev Goel & Associates, Advocates and Solicitors, 785, Pocket-E, Mayur Vihar-II, NH-24, Delhi-110 091, India,
Mobile: 093124 09354, e-mail: [email protected]. The aforesaid documents are also placed on the web-site of the Transferee Company: www.sterileindia.com.
21. Please note that Un-secured Creditors of the Transferor Company No. 1
and the Transferee Company may attend and vote in the respective meetings either in person or by proxies. Proxies need not be a member/creditor of the concerned Transferor Company or the
Transferee Company.
Dated this 21st March, 2018 For and on behalf of the Board of
Directors For Sterile API Pvt Ltd
Sd/- Sanjeev Goel Director
DIN: 00370189
For and on behalf of the Board of
Directors For Bluestar Dealers Pvt Ltd
Sd/- Prem Chand Goel Director
DIN: 02822907
For and on behalf of the Board of Directors
For Sach Technology Pvt Ltd
Sd/- Sanjeev Goel
Director DIN: 00370189
For and on behalf of the Board of Directors
For Avenue Gems & Jewels Pvt Ltd
Sd/- Sanjeev Goel
Director DIN: 00370189
For and on behalf of the Board of Directors For Sterile India Pvt Ltd
Sd/- Sanjeev Goel Director
DIN: 00370189
SCHEME OF AMALGAMATION
OF
STERILE API PVT LTD
BLUESTAR DEALERS PVT LTD
SACH TECHNOLOGY PVT LTD
AND
AVENUE GEMS & JEWELS PVT LTD
WITH
STERILE INDIA PVT LTD AND THEIR RESPECTIVE SHAREHOLDERS AND CREDITORS UNDER
SECTIONS 230 & 232 OF THE COMPANIES ACT, 2013, AND OTHER APPLICABLE PROVISIONS, IF ANY
1.1 DEFINITIONS
In this Scheme, unless repugnant to the meaning or context thereof, the following expressions shall have the meaning as under:
a. “Act” means the Companies Act, 2013 (18 of 2013), the Companies
(Compromises, Arrangements and Amalgamations) Rules, 2016, the
National Company Law Tribunal Rules, 2016, and any other Rules made there under, as the case may be applicable; and the Companies
Act, 1956 (1 of 1956), to the extent applicable, if any.
b. “Appointed Date” means commencement of business on 1st April,
2017, or such other date as the Hon’ble National Company Law Tribunal or any other competent authority may approve.
c. “Board of Directors” in relation to respective Transferor and
Transferee Companies, as the case may be, shall, unless it is
repugnant to the context or otherwise, include a Committee so authorised by the Board, or any person authorised by the Board of
Directors or such Committee.
d. “Effective Date” means the date on which the transfer and vesting of the entire undertakings of these Transferor Companies shall take effect, i.e., the date as specified in Clause 5 of this Scheme.
e. National Company Law Tribunal means appropriate Bench of the
Hon’ble National Company Law Tribunal constituted under the Companies Act, 2013, having territorial jurisdiction to sanction the present Scheme and other connected matters. The National Company
Law Tribunal has been referred to as the Tribunal/NCLT.
f. “Record Date” means the date to be fixed by the Board of Directors of the Transferor Companies No. 1 to 4 and/or the Transferee
Company, with reference to which the eligibility of the shareholders of the Transferor Companies, for allotment of shares in the Transferee
Company pursuant to the Amalgamation in terms of this Scheme, shall be determined.
g. “Scheme” means the present Scheme of Amalgamation framed
under the provisions of sections 230 and 232 of the Companies Act, 2013, and other applicable provisions, if any, where under the Transferor Companies are proposed to be amalgamated with the
Transferee Company in the present form or with any modification(s) approved or imposed or directed by Members/Creditors of the
respective Companies and/or by any competent authority and/or by the Hon’ble Tribunal or as may otherwise be deemed fit by the Board of Directors of these Companies.
h. “Transferor Company No. 1” means Sterile API Pvt Ltd being a
company incorporated under the provisions of the Companies Act, 1956, and having its registered office at 1705, 4th Floor, Onkar Bhawan, Bhagirath Palace, Chandni Chowk, Delhi-110 006, e-mail:
The Transferor Company No. 1-Sterile API Pvt Ltd [Corporate Identification No. (CIN): U 17121 DL 2007 PTC 168198; Income Tax Permanent Account No. (PAN): AAOC S 4612 H] (hereinafter referred
to as “the Transferor Company No. 1/the Company”) was originally incorporated under the provisions of the Companies Act, 1956, as a
private limited company with the name and Style as ‘Shree Radhey Krishna Spinners Pvt Ltd’ vide Certificate of Incorporation dated 14th September, 2007 issued by the Registrar of Companies, NCT of Delhi
and Haryana, New Delhi. The name of the Company was changed to ‘Jubilant Organics Pvt Ltd’ vide Fresh Certificate of Incorporation
dated 22nd December, 2014 issued by the Registrar of Companies, New Delhi. The name of the Company was changed to its present name ‘Sterile API Pvt Ltd’ vide Fresh Certificate of Incorporation dated
12th December, 2015 issued by the Registrar of Companies, New Delhi.
i. “Transferor Company No. 2” means Bluestar Dealers Pvt Ltd
being a company incorporated under the provisions of the Companies
Act, 1956, and having its registered office at 1705/5, 1st Floor, Bhagirath Palace, Delhi-110 006, e-mail: [email protected].
The Transferor Company No. 2-Bluestar Dealers Pvt Ltd [Corporate
Identification No. (CIN): U 51909 DL 2009 PTC 267614; Income Tax Permanent Account No. (PAN): AADC B 9292 K] (hereinafter referred to as “the Transferor Company No. 2/the Company”) was incorporated
under the provisions of the Companies Act, 1956, as a private limited company vide Certificate of Incorporation dated 18th December, 2009
issued by the Registrar of Companies, West Bengal, Kolkata. Registered Office of the Company was shifted from the State of West Bengal to the NCT of Delhi as approved by the Hon’ble Regional
Director, Eastern Region, Ministry of Corporate Affairs, Kolkata vide Order dated 31st March, 2014. The Registrar of Companies, Delhi &
Haryana, New Delhi registered the aforesaid order and allotted a new CIN to the Company.
j. “Transferor Company No. 3” means Sach Technology Pvt Ltd being a company incorporated under the provisions of the Companies
Act, 1956, and having its registered office at 1705/5, F/F, Bhagirath Palace, Delhi-110 006, e-mail: [email protected].
The Transferor Company No. 3-Sach Technology Pvt Ltd [Corporate
Identification No. (CIN): U 72900 DL 2009 PTC 267543; Income Tax Permanent Account No. (PAN): AANC S 2185 A] (hereinafter referred to as “the Transferor Company No. 3/the Company”) was incorporated
under the provisions of the Companies Act, 1956, as a private limited company vide Certificate of Incorporation dated 1st April, 2009 issued
by the Registrar of Companies, NCT of Delhi and Haryana, New Delhi. Registered Office of the Company was shifted from the State of Haryana to the NCT of Delhi as approved by the Hon’ble Regional
Director, Northern Region, Ministry of Corporate Affairs, New Delhi, vide Order dated 13th March, 2014. The Registrar of Companies, NCT
of Delhi and Haryana, New Delhi registered the aforesaid order on 7th April, 2014 and allotted a new CIN to the Company.
k. “Transferor Company No. 4” means Avenue Gems & Jewels Pvt Ltd being a company incorporated under the provisions of the
Companies Act, 1956, and having its registered office at 1705/5, 3rd
Floor, Bhagirath Palace, Delhi-110 006, e-mail: [email protected].
The Transferor Company No. 4-Avenue Gems & Jewels Pvt Ltd [Corporate Identification No. (CIN): U 52100 DL 2009 PTC 189939;
Income Tax Permanent Account No. (PAN): AAHC A 6961 G] (hereinafter referred to as “the Transferor Company No. 4/the Company”) was incorporated under the provisions of the Companies
Act, 1956, as a private limited company vide Certificate of Incorporation dated 1st May, 2009 issued by the Registrar of
Companies, NCT of Delhi and Haryana, New Delhi.
l. “Transferor Companies” mean Sterile API Pvt Ltd, Bluestar Dealers
Pvt Ltd, Sach Technology Pvt Ltd and Avenue Gems & Jewels Pvt Ltd, collectively or any one or more of them as the context requires.
m. “Transferee Company” means Sterile India Pvt Ltd being a
company incorporated under the provisions of the Companies Act,
1956, and having its registered office at Unit No. 501, 5th Floor, Aggarwal Corporate Heights, Plot No. A-7, Netaji Subhash Place,
Pitampura, New Delhi-110 034, e-mail: [email protected].
The Transferee Company-Sterile India Pvt Ltd [Corporate Identification No. (CIN): U 74899 DL 1989 PTC 036517; Income Tax Permanent Account No. (PAN): AAAC U 5331 M] (hereinafter referred
to as “the Transferee Company/the Company”) was originally incorporated under the provisions of the Companies Act, 1956, as a
private limited company with the name and Style as ‘Uniways Laboratories Pvt Ltd’ vide Certificate of Incorporation dated 5th June, 1989 issued by the Registrar of Companies, NCT of Delhi and
Haryana, New Delhi. The name of the Company was changed to ‘Sterile India Pvt Ltd’ vide Fresh Certificate of Incorporation dated 7th
July, 2010 issued by the Registrar of Companies, New Delhi.
1.2 SHARE CAPITAL
i. The present Authorised Share Capital of the Transferor Company No. 1 is ₹6,28,82,000 divided into 31,88,200 Equity Shares of ₹10 each
aggregating to ₹3,18,82,000; and 3,10,000 Preference Shares of ₹100
each aggregating to ₹3,10,00,000. The present Issued, Subscribed
and Paid-up Share Capital of the Company is ₹3,18,81,800 divided
into 31,88,180 Equity Shares of ₹10 each.
ii. The present Authorised Share Capital of the Transferor Company No. 2 is ₹12,90,000 divided into 1,29,000 Equity Shares of ₹10 each. The
present Issued, Subscribed and Paid Up Share Capital of the Company is ₹12,88,000 divided into 1,28,800 Equity Shares of ₹10 each.
iii. The present Authorised Share Capital of the Transferor Company No.
3 is ₹2,20,000 divided into 22,000 Equity Shares of ₹10 each. The
present Issued, Subscribed and Paid Up Share Capital of the Company is ₹2,20,000 divided into 22,000 Equity Shares of ₹10 each.
iv. The present Authorised Share Capital of the Transferor Company No.
4 is ₹1,00,000 divided into 10,000 Equity Shares of ₹10 each. The
present Issued, Subscribed and Paid Up Share Capital of the Company
is ₹1,00,000 divided into 10,000 Equity Shares of ₹10 each.
v. The present Authorised Share Capital of the Transferee Company is ₹25,00,00,000 divided into 25,00,000 Equity Shares of ₹100 each.
The present Issued, Subscribed and Paid-up Share Capital of the Company is ₹15,44,88,800 divided into 15,44,888 Equity Shares of
₹100 each.
vi. All the Transferor and the Transferee Companies are closely held
private limited Group Companies under common shareholding, management and control.
2. TRANSFER OF UNDERTAKING
a. With effect from the commencement of business on 1st April, 2017, i.e., the Appointed Date, subject to the provisions of the Scheme in
relation to the modalities of transfer and vesting, the undertaking and entire business and all immovable properties (including agricultural land, industrial land, residential land and all other land and plots)
where so ever situated and incapable of passing by physical delivery as also all other assets, capital work-in-progress, current assets,
investments, deposits, bookings and advances against residential and commercial plots and buildings, powers, authorities, awards,
allotments, approvals and consents, licenses, registrations, contracts, agreements, engagements, arrangement, rights, intellectual property rights, titles, interests, benefits and advantages of whatsoever nature
belonging to or in the ownership, power, possession, control of or vested in or granted in favour of or enjoyed by the Transferor
Companies, including but without being limited to, licenses granted by various government authorities for development of real estate projects, lease deeds, lease agreements, conveyance deed, registry,
sale agreements, purchase agreements, memorandum of
understanding (MOU), joint development agreement, joint venture agreements, award on successful bidding and/or auction, earnest
money, deposits, approval/NOC given by various government and other competent authorities like environmental clearances, approval
for land use change (CLU), completion certificate, approval/NOC from fire department, approval/NOC for water, electricity and sewerage,
clearance by airport authority, approval/NOC from irrigation department, approval/NOC from forest department, approval/NOC from underground water authority, approval/NOC from national
highway authority, approval/NOC from high tension department, all permits and licenses like liquor license, license to run restaurant,
lift/escalator license, liberties, easements, advantages, benefits, privileges, leases, tenancy rights, ownership, intellectual property rights including trademarks, brands, copy rights; quota rights,
subsidies, capital subsidies, concessions, exemptions, sales tax exemptions, concessions/ obligations under EPCG/Advance/DEPB
licenses, approvals, clearances, authorizations, certification, quality certification, utilities, electricity connections, electronics and computer link ups, services of all types, reserves, provisions, funds, benefit of
all agreements and all other interests arising to the Transferor Companies (hereinafter collectively referred to as “the said assets”)
shall, without any further act or deed or without payment of any duty or other charges, be transferred to and vested in the Transferee Company pursuant to the provisions of Section 232 of the Act, for all
the estate, right, title and interest of the Transferor Companies therein so as to become the property of the Transferee Company but,
subject to mortgages, charges and encumbrances, if any, then affecting the undertaking of the Transferor Companies without such charges in any way extending to the undertaking of the Transferee
Company.
b. Notwithstanding what is provided herein above, it is expressly provided that in respect to such of the said assets as are movable in nature or are otherwise capable of being transferred by physical
delivery or by endorsement and delivery, the same shall be so transferred, with effect from the appointed date, by the Transferor
Companies to the Transferee Company after the Scheme is duly sanctioned and given effect to without requiring any order of the Tribunal or any deed or instrument of conveyance for the same or
without the payment of any duty or other charges and shall become the property of the Transferee Company accordingly.
c. On and from the Appointed Date, all liabilities, provisions, duties and
obligations including Income Tax and other statutory liabilities, if any, of every kind, nature and description of the Transferor Companies whether provided for or not in the books of accounts of the Transferor
Companies shall devolve and shall stand transferred or be deemed to be transferred without any further act or deed, to the Transferee
Company with effect from the Appointed Date and shall be the liabilities, provisions, duties and obligations of the Transferee Company.
d. Similarly, on and from the Appointed Date, all the taxes and duties
including advance tax, tax deducted at source, tax collected at source, credit of MAT, self-assessment tax paid by or on behalf of the
Transferor Companies immediately before the amalgamation shall become or be deemed to be the property of the Transferee Company
by virtue of the amalgamation. Upon the Scheme becoming effective, all the taxes paid (including TDS) by the Transferor Companies from
the appointed date, regardless of the period to which they relate, shall be deemed to have been paid for and on behalf of and to the credit of
the Transferee Company as effectively as if the Transferee Company had paid the same.
e. Without prejudice to the generality of the provisions contained in aforesaid clauses, upon the Scheme becoming effective, requisite
form(s) will be filed with the Registrar of Companies for creation, modification and/or satisfaction of charge(s), to the extent required, to give effect to the provisions of this Scheme.
f. On the Scheme becoming effective, the Transferee Company shall be
entitled to file/revise income tax returns, TDS returns and other statutory filings and returns, filed by it or by the Transferor Companies, if required, and shall have the right to claim refunds,
depreciation benefits, advance tax credits, etc., if any.
g. All other assets & liabilities of the Transferor Companies, which may not be specifically covered in the aforesaid clauses, shall also stand transferred to the Transferee Company with effect from the Appointed
Date.
3. CONTRACTS, DEEDS, BONDS AND OTHER INSTRUMENTS
a. Subject to the other provisions of this Scheme, all contracts, deeds,
bonds, agreements and other instruments of whatsoever nature, to which the Transferor Companies is a party, subsisting or having effect
immediately before or after the Effective date, shall remain in full force and effect against or in favour of the Transferee Company and may be enforced as fully and effectually, as if instead of the
Transferor Companies, the Transferee Company had been a party thereto.
b. The transfer of the said assets and liabilities of the Transferor
Companies to the Transferee Company and the continuance of all the
contracts or legal proceedings by or against the Transferee Company shall not affect any contract or proceedings relating to the said assets
or the liabilities already concluded by the Transferor Companies on or after the Appointed Date.
c. The Transferee Company may, at any time after coming into effect of
this Scheme in accordance with the provisions hereof, if so required,
under any law or otherwise, execute deeds of confirmation in favour of the secured creditors of the Transferor Companies or in favour of
any other party to any contract or arrangement to which the Transferor Companies are a party or any writings as may be necessary to be executed in order to give formal effect to the above
provisions. The Transferee Company shall, under the provisions of this Scheme, be deemed to be authorised to execute any such writings on
behalf of the Transferor Companies and, to implement and carry out
all such formalities or compliance referred to above on the part/behalf of the Transferor Companies to be carried out or performed.
4. LEGAL PROCEEDINGS
All legal proceedings of whatever nature by or against the Transferor
Companies pending on the Effective Date, shall not be abated, be discontinued or be, in any way, prejudicially affected by reason of the transfer of the undertaking of the Transferor Companies or of
anything contained in this Scheme but the proceedings may be continued, prosecuted and enforced by or against the Transferee
Company in the same manner and to the same extent as it would or might have been continued, prosecuted and enforced by or against the Transferor Companies as if the Scheme had not been made.
5. OPERATIVE DATE OF THE SCHEME
a. This Scheme shall be effective from the last of the dates on which
certified copies of order of the Tribunal under Sections 230 and 232 of
the Companies Act, 2013, are filed in the office(s) of the concerned Registrar of Companies. Such date is called as the Effective Date.
b. Though this Scheme shall become effective from the Effective Date,
the provisions of this Scheme shall be applicable and come into
operation from the Appointed Date.
6. DISSOLUTION OF TRANSFEROR COMPANIES
On this Scheme, becoming effective as provided in Clause 5 above, the
Transferor Companies shall stand dissolved without the process of winding up.
7. EMPLOYEES OF TRANSFEROR COMPANIES
a. All the employees of the Transferor Companies in service on the date immediately preceding the date on which the Scheme finally takes
effect, i.e., the Effective Date, shall become the employees of the Transferee Company on such date without any break or interruption in service and upon terms and conditions not less favourable than those
subsisting in the concerned Transferor Company on the said date.
b. Provident Fund, Gratuity Fund, Superannuation Fund and any other special fund or trusts created or existing for the benefit of the
employees of the Transferor Companies, if any, upon the Scheme becoming finally effective, the Transferee Company shall stand substituted for the Transferor Companies for all purposes and intents,
whatsoever, relating to the administration or operation of such schemes or funds or in relation to the obligation to make contributions
to the said funds in accordance with the provisions of such funds. It is the intent that all the rights, duties, powers and obligations of the Transferor Companies in relation to such funds shall become those of
the Transferee Company. It is clarified that the services of the employees of the Transferor Companies will be treated as having been
continued for the purpose of the aforesaid funds or provisions.
8. CONDUCT OF BUSINESS BY TRANSFEROR & TRANSFEREE COMPANIES
From the Appointed Date until the Effective Date, the Transferor
Companies
a. Shall stand possessed of all its assets and properties referred to in Clause 2 above, in trust for the Transferee Company.
b. Shall be deemed to have carried on business and activities for and on behalf of and for the benefit and on account of the Transferee
Company. Any income or profit accruing to the Transferor Companies and all costs, charges and expenses or loss arising or incurring by the Transferor Companies on and from the Appointed Date shall, for all
purposes and intents, be treated as the income, profits, costs, charges, expenses or loss, as the case may be, of the Transferee
Company. 9. ISSUE OF SHARES BY TRANSFEREE COMPANY
9.1 Upon the Scheme finally coming into effect and in consideration of the
transfer and vesting of all the said assets and liabilities of the Transferor Companies to the Transferee Company in terms of the Scheme, the Transferee Company shall, without any further
application or deed, issue and allot Share(s) to the Shareholders of the Transferor Companies, whose names appear in the Register of
Members as on the Record Date, in the following ratio:
a. The Transferee Company will issue 1 (one) Equity Share of ₹100
each, credited as fully paid up, for every 27 (twenty-seven)
Equity Shares of ₹10 each held in the Transferor Company No. 1-
Sterile API Pvt Ltd.
b. The Transferee Company will issue 5 (five) Equity Shares of ₹100
each, credited as fully paid up, for every 4 (four) Equity Shares of ₹10 each held in the Transferor Company No. 2-Bluestar
Dealers Pvt Ltd.
c. The Transferee Company will issue 1 (one) Equity Share of ₹100
each, credited as fully paid up, for every 72 (seventy-two) Equity Shares of ₹10 each held in the Transferor Company No. 3-Sach
Technology Pvt Ltd.
d. The Transferee Company will issue 1 (one) Equity Share of ₹100
each, credited as fully paid up, for every 104 (one hundred four) Equity Shares of ₹10 each held in the Transferor Company No. 4-
Avenue Gems & Jewels Pvt Ltd.
9.2 Any fraction of share arising out of the aforesaid share exchange process, if any, will be rounded off to nearest whole number.
9.3 The Equity Shares to be issued in terms of Para 9.1 above shall be subject to the provisions of the Memorandum and Articles of
Association of the Transferee Company. New Equity Shares shall rank
pari passu in all respects, including dividend, with the existing Equity Shares of the Transferee Company.
9.4 The issue and allotment of Equity Shares by the Transferee Company,
as provided in this Scheme, is an integral part thereof. The members of the Transferee Company, on approval of the Scheme, shall be
deemed to have given their approval under sections 42 & 62 of the Companies Act, 2013, and other applicable provisions, if any, for issue of fresh Equity Shares in terms of this Scheme.
9.5 It is, however, clarified that provisions of this Scheme with regard to
issue of shares by the Transferee Company will not apply to the share application money, if any, which may remain outstanding in the Transferor Companies.
10. Upon this Scheme becoming finally effective:
a. Entire Issued Share Capital and share certificates of the Transferor
Companies shall automatically stand cancelled. Shareholders of the
Transferor Companies will not be required to surrender the Share Certificates held in the Transferor Companies.
b. Cross holding of shares between the Transferor Companies; and
between the Transferor Companies and the Transferee Company on
the record date, if any, shall stand cancelled. Approval of this Scheme by the Shareholders and/or Creditors of the Transferor and the
Transferee Companies, as the case may be, and sanction by the Tribunal under section 230 and 232 of the Companies Act, 2013, shall be sufficient compliance with the provisions of sections 66 of the
Companies Act, 2013, and other applicable provisions, if any, relating to the reduction of share capital on cancellation of cross holding, if
any. Such reduction would not involve either the diminution of any liability in respect of un-paid share capital or the payment to any shareholder of any paid-up share capital.
c. In terms of the provisions of section 232(3)(i) of the Companies Act,
2013, the authorised share capital of the Transferor Companies shall be added to and shall form part of the authorised share capital of the Transferee Company. Accordingly, the authorised share capital of the
Transferee Company shall stand increased to the extent of the aggregate authorised share capital of the Transferor Companies as on
the effective date, without payment of any fees or charges to the Registrar of Companies and/or to any other government authority.
Clause V of the Memorandum of Association and relevant article(s) of the Articles of Association of the Transferee Company shall stand modified to give effect to the aforesaid increase in the authorised
capital of the Transferee Company without any further approval.
d. Save as provided in Para 10.c above, the Transferee Company shall increase/modify its Authorized Share Capital for implementing the terms of the Scheme, to the extent necessary.
11. ACCOUNTING FOR AMALGAMATION
Upon the Scheme becoming effective, amalgamation of the Transferor Companies with the Transferee Company will be accounted for in
accordance with the applicable provisions of the Companies Act, 2013, Accounting Standards prescribed under section 133 of the Companies Act,
2013, and Generally Accepted Accounting Principles in India (Indian GAAP), as the case may be.
In terms of the Accounting Standard (AS) 14, amalgamation of the Transferor Companies with the Transferee Company will be accounted in
the following manner:
a. The amalgamation shall be an ‘amalgamation in the nature of merger’
as defined in the Accounting Standard (AS) 14 as prescribed under the Companies (Accounting Standards) Rules, 2006, and shall be
accounted for under the ‘pooling of interests’ method in accordance with the said AS-14.
b. Accordingly, all the assets and liabilities recorded in the books of the Transferor Companies shall be transferred to and vested in the
Transferee Company pursuant to the Scheme and shall be recorded by the Transferee Company at the respective book values as reflected in the books of the Transferor Companies as on the Appointed Date.
c. Cross investments or other inter-company balances, if any, will stand
cancelled.
d. All the reserves of the Transferor Companies under different heads
shall become the corresponding reserves of the Transferee Company. Similarly, balance in the Profit & Loss Accounts of the Transferor and
Transferee Companies will also be clubbed together.
e. In accordance with the Accounting Standard 14, any deficit arising out
of amalgamation (including on account of cancellation of cross holdings or any other inter-company balances) shall be adjusted
against reserves and surplus, if any, in the books of the Transferee Company. Whereas any surplus arising out of Amalgamation (including on account of cancelling of cross holdings or any other
inter-company balances) shall be credited to capital reserve.
f. Accounting policies of the Transferor Companies will be harmonized with that of the Transferee Company following the amalgamation.
It is, however, clarified that in case of applicability of the Ind AS as prescribed under the Companies (Indian Accounting Standards) Rules,
2015, amalgamation of the Transferor Companies with the Transferee Company will be accounted for in the manner as provided in the
applicable Ind AS.
12. APPLICATION TO NATIONAL COMPANY LAW TRIBUNAL
a. The Transferor Companies shall make joint/separate applications/ petitions under the provisions of sections 230 & 232 of the Companies
Act, 2013, the Companies (Compromises, Arrangements and Amalgamations) Rules, 2016, the National Company Law Tribunal
Rules, 2016, and other applicable provisions, if any, to the Hon'ble National Company Law Tribunal for sanctioning of this Scheme, dissolution of the Transferor Companies without the process of
winding up and other connected matters.
b. The Transferee Company shall also make joint/separate application(s)/petition(s) under the provisions of sections 230 & 232 of the Companies Act, 2013, the Companies (Compromises,
Arrangements and Amalgamations) Rules, 2016, the National Company Law Tribunal Rules, 2016 and other applicable provisions, if
any, to the Hon'ble National Company Law Tribunal for sanctioning of this Scheme and other connected matters.
13. MODIFICATIONS/AMENDMENTS TO THE SCHEME
a. The Transferor Companies and the Transferee Company through their respective Board of Directors may make or assent, from time to time, on behalf of all persons concerned, to any modifications or
amendments to this Scheme or to any conditions or limitations which the Tribunal and/or any authorities under the law may deem fit to
approve of or impose and to resolve all doubts or difficulties that may arise for carrying out this Scheme and to do and execute all acts, deeds, matters and things necessary for carrying the Scheme into
effect.
b. In order to give effect to this Scheme or to any modifications or amendments thereof, the Board of Directors of the Transferee Company may give and are authorised to give all such directions as
may be necessary including directions for settling any question, doubt or difficulty that may arise.
c. The Transferor Companies and/or the Transferee Company shall be at
liberty to withdraw from this Scheme in case any condition, alteration
or modification, imposed or suggested by the Tribunal or any other competent authority, is not acceptable to them; or as may otherwise
be deemed fit or proper by any of these Companies. The Transferor Companies and/or the Transferee Company will not be required to
assign the reason for withdrawing from this Scheme. 14. INTERPRETATION
If any doubt or difference or issue arises between the Transferor
Companies and the Transferee Company or any of their Shareholders or Creditors and/or any other person as to the construction hereof or as to anything else contained in or relating to or arising out of this Scheme, the
same shall be referred to Mr Rajeev K Goel, LLB, FCS, Advocate, 785, Pocket-E, Mayur Vihar II, NH-24, Delhi 110 091, Phone 93124 09354, e-
mail: [email protected] whose decision shall be final and binding on all concerned.
15. EXPENSES CONNECTED WITH THE SCHEME
All costs, charges and expenses of the Transferor Companies and the Transferee Company incurred in relation to or in connection with this
Scheme or incidental to the completion of the Amalgamation of the Transferor Companies with the Transferee Company in pursuance of this
Scheme, shall be borne and paid by the Transferee Company. However, in the event of the Scheme becoming invalid for any reason whatsoever, all costs, charges and expenses relating to the amalgamation exercise or
incidental thereto shall be borne and paid by the respective Companies incurring the same.
___________________
STERILE API PRIVATE LIMITEDCIN: U17121DL2007PTC168198BALANCE SHEET AS AT 31ST DECEMBER, 2017
NOTE As atNO. 31st December 2017
(Rs.)
I. EQUITY AND LIABILITIES(1) Shareholders’ Funds
Share Capital 1 31,881,800 Reserves and Surplus 2 57,012,378
88,894,178 (2) Current Liabilities
Short Term Borrowings 3 62,340,000 Trade Payables 4 27,261,374 Other Current Liabilities 5 1,698,149
91,299,523
TOTAL (1+2) 180,193,702 II. ASSETS(1) Non-Current Assets
Property, Plant and Equipment 6 140,804,477 Capital Work In Progress 7 - Deferred Tax Assets (Net) 8 20,363,317 Long Term Loans & Advances 9 582,250
161,750,044
(2) Current AssetsTrade Receivables 10 16,815 Cash and Bank Balances 11 5,271,768 Short Term Loans & Advances 12 13,121,500 Other Current Assets 13 33,575
18,443,658
TOTAL (1+2) 180,193,702
Notes to Financial Statements 1 to 21
The accompanying notes form an integral part of the Financial Statements
Sd/- Sd/- (SANJEEV GOEL) (NALESH GUPTA) Director Director
DIN: 00370189 DIN: 05154036
Place : DelhiDate : January 05, 2018
PARTICULARS
For STERILE API PRIVATE LIMITED
STERILE API PRIVATE LIMITEDCIN: U17121DL2007PTC168198STATEMENT OF PROFIT AND LOSS FOR THE PERIOD ENDED 31ST DECEMBER, 2017
PARTICULARS NOTE Period endedNO. 31st December 2017
(Rs.)
INCOMERevenue From Operations (Gross) 14 199,422,153 Less: Excise Duty 384,342 Revenue From Operations (Net) 199,037,811
Total Revenue ( I ) 199,037,811
EXPENSESCost of Material Consumed 15 196,681,481 Employee Benefits Expense 16 3,641,132 Finance Costs 17 942,232 Depreciation & Amortization Expense 6 10,410,148 Other Expenses 18 16,178,389 Total expenses ( II ) 227,853,383
Profit/(Loss) Before Tax and prior period items ( I-II ) (28,815,572)
Less: Tax Expense:(i) Current Tax - (ii) Deferred Tax Charge / (Credit) (10,317,093) Profit/(Loss) after tax but before prior period items (18,498,479)
Less: Prior Period ItemsPrior Period Expense 19 54,837
54,837
Profit/(Loss) for the period (18,553,316)
Basic Earnings Per Equity Share 20 (5.82)
Notes to Financial Statements 1 to 21
The accompanying notes form an integral part of the Financial Statements
Sd/- Sd/- (SANJEEV GOEL) (NALESH GUPTA) Director Director
DIN: 00370189 DIN: 05154036
Place : DelhiDate : January 05, 2018
For STERILE API PRIVATE LIMITED
STERILE API PRIVATE LIMITEDCIN: U17121DL2007PTC168198NOTES FORMING PART OF THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31ST DECEMBER 2017
PARTICULARS
NOTE - 1SHARE CAPITAL
No. of shares as at As at31st December 2017 31st Mar 2017 31st December 2017
Authorised share capital *Equity shares of Rs. 10/- each 3,188,200 100,000 31,882,000 Preference Shares of Rs. 100/- each 310,000 - 31,000,000
3,498,200 100,000 62,882,000
Issued, subscribed & paid up share capital Equity shares, fully paid up of Rs. 10/- eachIssued & paid up at the beginning of the period: 88,180 88,180 881,800 Add: Conversion of Preference to Equity**: 3,100,000 31,000,000 Add: Issued & paid up during the period: - - - Issued & paid up at the end of the period: 3,188,180 88,180 31,881,800
Details of shareholders holding more than 5% shares:
PARTICULARSNo. of Shares % held No. of Shares
Equity Shares, fully paid up of Rs. 10/- eachSterile India Pvt. Ltd 2,501,000 78.45 Sanjeev Goel 617,765 19.38 17,765
Terms / rights attached to Equity Shares
As at31st Mar 2017
As at31st December 2017
*The Company in Extra-Ordinary General Meeting held on 24th July, 2017 increased and altered its Authorised Share Capital from theexisting Rs 3,65,00,000 (Rupees Three Crores Sixty Five Lakhs) divided into 1,00,000 (One Lakh) equity shares of Rs 10 each and3,55,000 (Three Lakhs Fifty Five Thousand) Preference Shares of Rs 100 each, to Rs 6,28,82,000 (Rupees Six Crores Twenty EightLakhs Eighty Two Thousand) divided into 31,88,200 (Thirty One Lakhs Eighty Eight Thousand Two Hundred) equity shares of Rs 10each and 3,10,000 (Three Lakhs Ten Thousand) Prefernce Shares of Rs 100 each and the Company during the period re-classified
exisiting 45,000 (Forty Five Thousand) Preference Shares of Rs 100 each into 4,50,000 (Four Lakh Fifty Thousand) Equity Shares of Rs
10 each.
** The Company during the period converted 31,000.(Thirty One Thousand) Preference Shares of Rs 100 each into 31,00,000 (ThirtyOne Lakh) Equity Shares of Rs 10 each.
The Company has only one class of equity shares having a par value of Rs. 10/- per share. All the Equity Shares carry the same rightswith respect to voting, dividends etc.In the event of liquidation of the company, the holders of equity shares will be entitled to receive remaining assets of the company,after distribution of all preferential amounts. The distribution will be in proportion to the number of equity shares held by theshareholders.
STERILE API PRIVATE LIMITEDCIN: U17121DL2007PTC168198NOTES FORMING PART OF THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31ST DECEMBER 2017
PARTICULARS
NOTE - 2 As atRESERVES AND SURPLUS 31st December 2017Securities Premium Reserve
Opening Balance 106,978,200 Addition during the period - Closing Balance (A) 106,978,200
Surplus / (deficit) in the statement of profit & lossBalance as per last year (31,412,506) Add: Profit/ (Loss) after tax for period (18,553,316) Net surplus/ (deficit) (B) (49,965,822)
TOTAL RESERVES AND SURPLUS (A)+(B) 57,012,378
NOTE - 3 As atSHORT TERM BORROWINGS 31st December 2017Loans repayable on demand
Unsecured Loan:Loans from related parties (unsecured) 62,340,000
62,340,000
NOTE - 4 As atTRADE PAYABLES 31st December 2017
Total outstanding dues of micro and small enterprises - Total outstanding dues of creditors other than micro and small enterprises 27,261,374
27,261,374
NOTE - 5 As atOTHER CURRENT LIABILITIES 31st December 2017Interest accrued but not due on borrowings 940,137 Others Payables
Statutory Dues Payable 167,788 Expenses Payable 590,224
1,698,149
NOTE - 8 As atDEFERRED TAX ASSETS (NET) 31st December 2017Deferred tax Assets on account of:
9,531,483 12,820,286
Less: Deferred tax liability on account of:1,988,452
20,363,317
-- Fixed Assets: Impact of difference between tax depreciation and depreciation charged for financial reporting
-- Impact of Business Loss carried forward-- Impact of Unabsorbed Depreciation
STERILE API PRIVATE LIMITEDCIN: U17121DL2007PTC168198NOTES FORMING PART OF THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31ST DECEMBER, 2017
NOTE - 6PROPERTY, PLANT AND EQUIPMENT
Net Block
Sr. No Particulars As on 01-04-2017
Addition during the
period
Sales/ Adjustment during the period
As on 31-12-2017
As on 01-04-2017
During the period
Adjustment during the
period
As on 31-12-2017
As on 31-12-2017
Tangible Assets1 Land 35,966,039 1,222,300 37,188,339 - - - 37,188,339
2 Plant and Machinery 80,723,283 45,443,841 - 126,167,124 33,023,014 8,889,940 - 41,912,954 84,254,170
3 Furniture and fittings 290,000 - - 290,000 203,302 17,737 221,039 68,961
4 Electrical Installations and Equipment 1,392,032 - 1,392,032 167,215 239,753 406,968 985,064
5 Hydraulic works, pipelines and sluices 2,536,521 2,536,521 142,119 251,863 393,982 2,142,539
6 Building - 17,176,259 - 17,176,259 1,010,855 1,010,855 16,165,404
TOTAL 120,907,875 63,842,400 - 184,750,276 33,535,650 10,410,148 - 43,945,798 140,804,477
NOTE - 7Capital Work in Progress
Net Block
Sr. No Particulars As on 01-04-2017
Addition during the
period
Sales/ Adjustment during the period
As on 31-12-2017
As on 01-04-2017
During the period
Adjustment during the
period
As on 31-12-2017
As on 31-12-2017
1 Building Under Construction 16,276,569 899,690 17,176,259 - - - - - - 2 Plant & Machinery WIP 39,521,909 - 39,521,909 - - - - - -
Grand Total 55,798,478 899,690 56,698,168 - - - - - -
Sd/- Sd/-(SANJEEV GOEL) (NALESH GUPTA)Director DirectorDIN: 00370189 DIN: 05154036
Gross Block Accumulated Depreciation
Gross Block Accumulated Depreciation
For STERILE API PRIVATE LIMITED
STERILE API PRIVATE LIMITEDCIN: U17121DL2007PTC168198NOTES FORMING PART OF THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31ST DECEMBER 2017
PARTICULARS
NOTE - 9 As atLONG TERM LOANS & ADVANCES 31st December 2017(Unsecured, considered good)
Security Deposit 582,250 582,250
NOTE - 10TRADE RECEIVABLESUnsecured, considered good
Debts outstanding for a period exceeding six months - Others 16,815
16,815
Debts due by Companies where Company's Director is a Director or member 16,815
NOTE - 11 As atCASH AND BANK BALANCES 31st December 2017Cash and Cash Equivalents
Cash in hand (as certified by the management) 1,133,266 Balance with Banks 4,138,502
5,271,768
NOTE - 12 As atSHORT TERM LOANS & ADVANCES 31st December 2017Unsecured, Considered good
OthersAdvances recoverable in cash or in kind or for value to be received and/or adjusted- Suppliers and Service Providers 3,057,620
Tax Credit 10,063,880 13,121,500
NOTE - 13 As atOTHER CURRENT ASSETS 31st December 2017Interest Accrued on Security Deposit 33,575
33,575
NOTE - 14 Period endedREVENUE FROM OPERATIONS (GROSS) 31st December 2017Sale of Products 199,422,153
199,422,153
STERILE API PRIVATE LIMITEDCIN: U17121DL2007PTC168198NOTES FORMING PART OF THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31ST DECEMBER 2017
PARTICULARS
NOTE - 15 Period endedCOST OF MATERIAL CONSUMED 31st December 2017Raw Materials
Inventories at the beginning of the year: - Add: Purchases 196,681,481
196,681,481 Less: Inventories at the end of the period:
Cost of raw materials Consumed 196,681,481
Total cost of material consumed 196,681,481
NOTE - 16 Period endedEMPLOYEE BENEFITS EXPENSE 31st December 2017
Salaries & Wages 3,417,502 Employer's Contribution to PF & ESI 189,220 Employer's Contribution to Labour Welfare Fund 3,960 Staff Welfare expenses 30,450
3,641,132
NOTE - 17 Period endedFINANCE COSTS 31st December 2017
Interest Expense 2,095 Interest on Unsecured Loan 940,137
942,232
NOTE - 18 Period endedOTHER EXPENSES 31st December 2017
Power & Fuel 14,848,711 Repair & Maintenance Expenses - Plant & Machinery 108,134 Legal & Professional Charges 2,190 Audit Fees 75,000 Miscellaneous Expenses 1,144,354
16,178,389
NOTE - 19PRIOR PERIOD EXPENSES
Maintenance charges 54,837 54,837
NOTE - 20 Period endedEARNINGS PER SHARE 31st December 2017Net Profit/(Loss) attributable to Equity Shareholders (Rs.) (18,553,316) Weighted Average Number of Equity Shares 3,188,180 Basic Earnings Per Equity Share (Rs.) (5.82) Nominal Value Per Equity Share (Rs.) 10.00
For STERILE API PRIVATE LIMITED
Sd/- Sd/- (SANJEEV GOEL) (NALESH GUPTA) Director Director
DIN: 00370189 DIN: 05154036Place : DelhiDate : January 05, 2018
Refer
Note No. AS AT 31.12.2017 AS AT
31.03.2017
I. EQUITY AND LIABILITIES
1 Shareholders’ funds(a) Share capital 1 1,288,000.00 1,288,000.00 (b) Reserves and surplus 2 119,758,578.38 118,975,871.38 (c) Money received against share warrants - -
2 Share application money pending allotment
3 Non-current liabilities
(a) Long-term borrowings - - (b) Deferred tax liabilities (Net) - - (c) Other Long term liabilities - - (d) Long-term provisions - -
4 Current liabilities(a) Short-term borrowings 3 70,000.00 40,000.00 (b) Trade payables - - (c) Other current liabilities 4 57,500.00 82,500.00 (d) Short-term provisions 5 42,513.00 12,376.00
121,216,591.38 120,398,747.38
II. ASSETS
Non-current assets 1 (a) Fixed assets
(i) Tangible assets - - (ii) Intangible assets - - (iii) Capital work-in-progress - - (iv) Intangible assets under development - -
(b) Non-current investments 6 81,148,000.00 81,148,000.00 (c) Deferred tax assets (net) - - (d) Long-term loans and advances 7 39,740,000.00 39,040,000.00 (e) Other non-current assets - -
2 Current assets(a) Current investments(b) Inventories - - (c) Trade receivables 8 150,480.00 98,325.00 (d) Cash and cash equivalents 9 153,349.38 107,247.38 (e) Short-term loans and advances - - (f) Other current assets 10 24,762.00 5,175.00
TOTAL 121,216,591.38 120,398,747.38
The accompanying notes form an integral part of the standalone financial statements
Date:- 05.01.2018Place:- Delhi
Sd/- Sd/- (Vidya Sagar Aggarwal) (Prem chand Goel)
Director DirectorDIN:- 06673575 DIN:- 02822907
For and on behalf of the Board
P A R T I C U L A R S
BLUESTAR DEALERS PRIVATE LIMITED1705/5,1st Floor, Bhagirath Palace, Chandni Chowk, Delhi-110006
Unaudited Balance Sheet as on 31.12.2017CIN: U51909DL2009PTC267614
P A R T I C U L A R S
Refer Note No.
Figures for the current reporting period
Figures for the previous reporting period
I. Revenue from operations - -
II. Other Income 11 865,872.00 700,099.00
III. Total Revenue (I + II) 865,872.00 700,099.00
IV. Expenses:Cost of materials consumed - - Purchases of Stock-in-Trade - - Changes in inventories of finished goods work-in-progress and Stock-in-Trade - - Employee benefits expense 12 20,416.00 25,784.00 Finance costs - - Depreciation and amortization expense - - Other expenses 13 32,612.00 39,755.00
Total expenses 53,028.00 65,539.00
V. Profit before exceptional and extraordinary items and tax (III-IV) 812,844.00 634,560.00
VI. Exceptional items - -
VII. Profit before extraordinary items and tax (V - VI) 812,844.00 634,560.00
VIII. Extraordinary Items - -
IX. Profit before tax (VII- VIII) 812,844.00 634,560.00
X Tax expense:(1) Current tax 30,137.00 12,376.00 (2) Deferred tax - -
XI Profit (Loss) for the period from continuing
operations (IX-X) 782,707.00 622,184.00
XII Profit/(loss) from discontinuing operations - -
XIII Tax expense of discontinuing operations - -
XIVProfit/(loss) from Discontinuing operations (after tax) (XII-XIII) - -
XV Profit (Loss) for the period (XI + XIV) 782,707.00 622,184.00 XVI Earnings per equity share:
(1) Basic (2) Diluted
The accompanying notes form an integral part of the standalone financial statements
Date:- 05.01.2018Place:- Delhi
Sd/- Sd/- (Vidya Sagar Aggarwal) (Prem chand Goel)
Director DirectorDIN:- 06673575 DIN:- 02822907
For and on behalf of the Board
CIN: U51909DL2009PTC267614
BLUESTAR DEALERS PRIVATE LIMITED
Unaudited Profit and loss statement for the year ended 31ST DECEMBER 20171705/5,1st Floor, Bhagirath Palace, Chandni Chowk, Delhi-110006
P A R T I C U L A R S AS ON 31.12.2017 AS ON 31.3.2017
NOTE: 1Share Capital
Authorised Capital 1,290,000.00 1,290,000.00 129000 Equity Shares of Rs.10/ each 1,290,000.00 1,290,000.00
Issued Subscribed & Paid up Capital128800 Equity Shares Of Rs. 10/-each fully paid up 1,288,000.00 1,288,000.00
1,288,000.00 1,288,000.00
Details of shares held No of shares held No of shares held M/s Sach Technology Private Limited 64,150.00 64,150.00 M/s Avenue Gems & Jewels Private Limited 64,150.00 64,150.00
128,300.00 128,300.00
NOTE: 2Reserves & Surplus
a) Securities Premium accountOpeining Balance 117,612,000.00 117,612,000.00 Add: Premium on Share issued during the year - - others (give detail) - - Closing Balance A 117,612,000.00 117,612,000.00 Surplus (Profit /Loss)Balance brought forward from last year 1,363,871.38 741,687.38 Add: Profit / (Loss) for the year 782,707.00 622,184.00 Approrpiations - - Closing Balance B 2,146,578.38 1,363,871.38 Total (A+ B) 119,758,578.38 118,975,871.38
NOTE:3Short Term borrowingsUnsecured LoansFrom Companies - - From Directors & their relatives 70,000.00 40,000.00
70,000.00 40,000.00
NOTE: 4Other current liabilitiesExpenses Payable 57,500.00 82,500.00
- - 57,500.00 82,500.00
NOTE: 5Short Term ProvisionsProv for Income Tax 42,513.00 12,376.00
42,513.00 12,376.00
Sd/- Sd/- (Vidya Sagar Aggarwal) (Prem chand Goel)
Director Director DIN:- 06673575 DIN:- 02822907
NOTES FORMING PART OF BALANCE SHEET AS ON 31ST DECEMBER, 2017
For and on behalf of the Board
BLUESTAR DEALERS PRIVATE LIMITED
P A R T I C U L A R S AS ON 31.12.2017 AS ON 31.3.2017NOTE: 6Non-current investmentsA) Other Investment a) Investment in equity instrumentsi) of other entities 81,148,000.00 81,148,000.00
b) Other non-current investment - -
81,148,000.00 81,148,000.00
NOTE: 7Long-term loans and advancesi) Other Loans and Advances ‐ Sterile API 39,040,000.00 39,040,000.00 ii) Loan to others 700,000.00 -
39,740,000.00 39,040,000.00
NOTE: 8Trade Receivables(Unsecured Considered Good)Outstanding for a period exceeding six months - - Other Debtors 150,480.00 98,325.00
150,480.00 98,325.00
NOTE: 9Cash and cash equivalents(a) Cash in hand 2,796.00 824.00 (b) Balances with Scheduled Banks
Current Account 150,553.38 106,423.38
153,349.38 107,247.38
NOTE: 10Other Current AssetsTDS 13,095.00 5,175.00 Interest Recievable 11,667.00
24,762.00 5,175.00
For and on behalf of the Board
Sd/- Sd/- (Vidya Sagar Aggarwal) (Prem chand Goel)
Director DirectorDIN:- 06673575 DIN:- 02822907
NOTES FORMING PART OF BALANCE SHEET AS ON 31ST DECEMBER , 2017
BLUESTAR DEALERS PRIVATE LIMITED
P A R T I C U L A R S
NOTE: 11Other IncomeDividend 695,805.00 596,404.00 Commission Income 158,400.00 103,500.00 Income Tax Refund - 195.00 Interest Income 11,667.00
865,872.00 700,099.00
NOTE: 12Employee benefits expenseSalary 17,850.00 23,800.00 Staff Welfare 2,566.00 1,984.00
20,416.00 25,784.00
NOTE: 13Other ExpensesAccounting Charges 5,175.00 6,000.00 Audit Fees - 20,000.00 Bank Charges - 115.00 Conveyance Exp. 3,395.00 4,120.00 Filing Expenses 14,400.00 - Printing & Stationary 2,269.00 1,806.00 Travelling Exp. 3,851.00 3,802.00 Telephone Exp. 3,522.00 3,912.00
32,612.00 39,755.00
Sd/- Sd/- (Vidya Sagar Aggarwal) (Prem chand Goel)
Director DirectorDIN:- 06673575 DIN:- 02822907
For and on behalf of the Board
BLUESTAR DEALERS PRIVATE LIMITED
NOTES FORMING PART OF PROFIT AND LOSS ACCOUNT AS ON 31ST DECEMBER, 2017
Refer
Note No. AS AT
31.12.2017 AS AT
31.03.2017
I. EQUITY AND LIABILITIES
1 Shareholders’ funds(a) Share capital 1 220,000.00 220,000.00 (b) Reserves and surplus 2 114,182.47 309.52 (c) Money received against share warrants - -
2 Share application money pending allotment
3 Non-current liabilities
(a) Long-term borrowings (b) Deferred tax liabilities (Net) 2,842.00 (c) Other Long term liabilities - - (d) Long-term provisions - -
4 Current liabilities(a) Short-term borrowings 3 43,500.00 87,000.00 (b) Trade payables 4 12,150.00 15,000.00 (c) Other current liabilities - (d) Short-term provisions 5 53,195.00 18,979.00
443,027.47 344,130.52
II. ASSETS
Non-current assets 1 (a) Fixed assets
(i) Tangible assets - 1,933.30 (ii) Intangible assets - - (iii) Capital work-in-progress - - (iv) Intangible assets under development - -
(b) Non-current investments 6 128,300.00 128,300.00 (c) Deferred tax assets (net) - - (d) Long-term loans and advances - - (e) Other non-current assets - -
2 Current assets(a) Current investments(b) Inventories - - (c) Trade receivables 7 267,710.00 87,875.00 (d) Cash and cash equivalents 8 32,927.47 121,397.22 (e) Short-term loans and advances - (f) Other current assets 9 14,090.00 4,625.00
TOTAL 443,027.47 344,130.52
The accompanying notes form an integral part of the standalone financial statements
Date:- 05.01.2018Place:- Delhi
(Sanjeev Goel) Director
DIN: 00370189
(Vidya Sagar Aggarwal) Director
DIN: 06673575
P A R T I C U L A R S
SACH TECHNOLOGY PRIVATE LIMITED1705/5,F/F, Bhagirath Palace, Delhi-110006
Unaudited Balance Sheet as on 31.12.2017
For and on behalf of the Board
CIN NO. U72900DL2009PTC267543
Sd/- Sd/-
P A R T I C U L A R SRefer Note
No. Figures for the current reporting period
Figures for the previous reporting period
I. Revenue from operations - -
II. Other Income 10 189,300.00 92,500.00
III. Total Revenue (I + II) 189,300.00 92,500.00
IV. Expenses:Cost of materials consumed - - Purchases of Stock-in-Trade - -
Changes in inventories of finished goods work-in-progress and Stock-in-Trade - - Employee benefits expense - - Finance costs - - Depreciation and amortization expense - 875.00 Other expenses 11 44,053.05 30,567.65
Total expenses 44,053.05 31,442.65
V.Profit before exceptional and extraordinary items and tax (III-IV) 145,246.95 61,057.35
VI. Exceptional items - -
VII. Profit before extraordinary items and tax (V - VI) 145,246.95 61,057.35
VIII. Extraordinary Items - -
IX. Profit before tax (VII- VIII) 145,246.95 61,057.35
X Tax expense:(1) Current tax 34,216.00 18,979.00 (2) Deferred tax (2,842.00) (1,136.44) (3) Provision for Tax W/o related to prior years - -
XIProfit (Loss) for the period from continuing operations (IX-X) 113,872.95 43,214.79
XII Profit/(loss) from discontinuing operations - -
XIII Tax expense of discontinuing operations - -
XIV Profit/(loss) from Discontinuing operations (after tax) (XII-XIII) - -
XV Profit (Loss) for the period (XI + XIV) 113,872.95 43,214.79 XVI Earnings per equity share:
(1) Basic - (2) Diluted -
The accompanying notes form an integral part of the standalone financial statements
Date:- 05.01.2018Place:- Delhi
Sd/- (Sanjeev Goel)
Director DIN: 00370189
For and on behalf of the Board
(Vidya Sagar Aggarwal) Director
DIN: 06673575
Unaudited Profit and loss statement for the year ended 31ST DECEMBER, 2017
Sd/-
SACH TECHNOLOGY PRIVATE LIMITED1705/5,F/F, Bhagirath Palace, Delhi-110006
CIN NO. U72900DL2009PTC267543
P A R T I C U L A R S AS ON 31.12.2017 AS ON 31.3.2017
NOTE: 1Share Capital
Authorised Capital 220,000.00 220,000.00 22000 Equity Shares of Rs.10/ each 220,000.00 220,000.00
Issued Subscribed & Paid up Capital22000 Equity Shares Of Rs. 10/-each fully paid up 220,000.00 220,000.00
220,000.00 220,000.00
Details of shares held No of shares held No of shares held Sanjeev Goel Huf 9,000.00 9,000.00 Vidya Sagar Aggarwal 4,000.00 4,000.00 Rajni Goel 9,000.00 9,000.00
22,000.00 22,000.00
NOTE: 2Reserves & Surplus - -
A - - Surplus (Profit /Loss)Balance brought forward from last year 309.52 (42,905.27) Add: Profit / (Loss) for the year 113,872.95 43,214.79 Approrpiations - - Closing Balance B 114,182.47 309.52 Total (A+ B) 114,182.47 309.52
NOTE: 3Short-term borrowings Unsecured Loans From Companies - - From Directors & their relatives 43,500.00 87,000.00
43,500.00 87,000.00 NOTE: 4Other current liabilitiesExpenses Payable 12,150.00 15,000.00
12,150.00 15,000.00 NOTE: 5Short - Term ProvisionsProv for Income Tax 53,195.00 18,979.00
53,195.00 18,979.00
Sd/- Sd/- (Sanjeev Goel)
Director DIN: 00370189
For and on behalf of the Board
(Vidya Sagar Aggarwal) Director
DIN: 06673575
SACH TECHNOLOGY PRIVATE LIMITED
NOTES FORMING PART OF BALANCE SHEET AS ON 31ST DECEMBER 2017
AS ON 31.12.2017 AS ON 31.3.2017NOTE: 6Non- current investment(a) Investment Property (specify nature), (net off accumulated - - depreciation and impairement, if any)
(b) Investment in equity instruments (give details separately for fully/partly paid of instruments)
(i) of subsidiaries - - (ii) of associates - - (iii) of joint venture companies - - (iv) of controlled special purpose entities - - (v) of other entities (give details) 128,300.00 128,300.00
128,300.00 128,300.00
NOTE: 7Trade Receivables(Unsecured considered Good)Outstanding for a period exceeding six months - - Other Debts 267,710.00 87,875.00
267,710.00 87,875.00
NOTE: 8Cash and cash equivalents(a) Cash in hand 1,536.00 89,682.00 (b) Balances with Scheduled Banks 31,391.47 31,715.22
32,927.47 121,397.22
NOTE: 9Other Current AssetsTDS 14,090.00 4,625.00
14,090.00 4,625.00
Sd/- Sd/- (Vidya Sagar Aggarwal) (Sanjeev Goel)
Director DirectorDIN: 06673575 DIN: 00370189
For and on behalf of the Board
P A R T I C U L A R S
SACH TECHNOLOGY PRIVATE LIMITED
NOTES FORMING PART OF BALANCE SHEET AS ON 31ST DECEMBER 2017
P A R T I C U L A R S
NOTE: 10Other IncomeCommission Income 189,300.00 92,500.00 -
189,300.00 92,500.00 NOTE: 11Other ExpensesAudit Fees - 15,000.00 Accounting Charges 6,600.00 4,000.00 Bank Charges 323.75 114.88 Filling Fees 10,800.00 - Legal & Professional Exp. 8,250.00 5,000.00 Misc. Exp. 7,250.00 4,394.00 Other Expenses 1,058.00 2,058.77 Assets written Off 1,933.30 - Conveyance expenses 1,988.00 - Telephone Expenses 350.00 - Printing and Stationary 5,500.00 -
44,053.05 30,567.65
Sd/- Sd/- (Vidya Sagar Aggarwal) (Sanjeev Goel)
Director DirectorDIN: 06673575 DIN: 00370189
For and on behalf of the Board
NOTES FORMING PART OF PROFIT AND LOSS ACCOUNT AS ON 31ST DECEMBER, 2017
SACH TECHNOLOGY PRIVATE LIMITED
Refer Note No.
AS AT 31.12.2017
AS AT 31.03.2017
I. EQUITY AND LIABILITIES
1 Shareholders’ funds(a) Share capital 1 100,000.00 100,000.00 (b) Reserves and surplus 2 45,341.00 (28,999.00) (c) Money received against share warrants - -
2 Share application money pending allotment
3 Non-current liabilities
(a) Long-term borrowings 3 64,000.00 54,000.00 (b) Deferred tax liabilities (Net) - - (c) Other Long term liabilities - - (d) Long-term provisions - -
4 Current liabilities(a) Short-term borrowings - - (b) Trade payables - - (c) Other current liabilities 4 4,560.00 10,000.00 (d) Short-term provisions 5 25,781.00 -
239,682.00 135,001.00
II. ASSETS
Non-current assets 1 (a) Fixed assets
(i) Tangible assets - - (ii) Intangible assets - - (iii) Capital work-in-progress - - (iv) Intangible assets under development - -
(b) Non-current investments 6 128,300.00 128,300.00 (c) Deferred tax assets (net) - - (d) Long-term loans and advances - - (e) Other non-current assets - -
2 Current assets(a) Current investments(b) Inventories - - (c) Trade receivables 7 103,250.00 - (d) Cash and cash equivalents 8 1,382.00 6,701.00 (e) Short-term loans and advances - - (f) Other current assets 9 6,750.00 -
TOTAL 239,682.00 135,001.00
The accompanying notes form an integral part of the standalone financial statements
Date: 05.01.2018 For and on behalf of the BoardPlace: Delhi
Sd/- Sd/- (Hema Gupta) (Sanjeev Goel)
Director DirectorDIN: 06673595 DIN: 00370189
P A R T I C U L A R S
AVENUE GEMS & JEWELS PRIVATE LIMITED1705/05,3rd Floor, Bhagirath Palace, North Delhi, Delhi-110006
Unaudited Balance Sheet as on 31.12.2017CIN U52100DL2009PTC189939
P A R T I C U L A R S
Refer Note No.
Figures for the current reporting period
Figures for the previous reporting period
I. Revenue from operations - -
II. Other Income 10 1,35,000.00 22,500.00
III. Total Revenue (I + II) 1,35,000.00 22,500.00
IV. Expenses:Cost of materials consumed - Purchases of Stock-in-Trade - - Changes in inventories of finished goods work-in-progress and Stock-in-Trade - - Employee benefits expense - - Finance costs - - Depreciation and amortization expense - - Other expenses 11 34,879.00 23,086.00
Total expenses 34,879.00 23,086.00
V. Profit before exceptional and extraordinary items and tax (III-IV) 1,00,121.00 (586.00)
VI. Exceptional items - -
VII. Profit before extraordinary items and tax (V - VI) 1,00,121.00 (586.00)
VIII. Extraordinary Items - -
IX. Profit before tax (VII- VIII) 1,00,121.00 (586.00)
X Tax expense:(1) Current tax 25,781.00 - (2) Deferred tax - -
XI Profit (Loss) for the period from continuing operations (IX-X) 74,340.00 (586.00)
XII Profit/(loss) from discontinuing operations - -
XIII Tax expense of discontinuing operations - -
XIVProfit/(loss) from Discontinuing operations (after tax) (XII-XIII) - -
XV Profit (Loss) for the period (XI + XIV) 74,340.00 (586.00) XVI Earnings per equity share:
(1) Basic - (2) Diluted -
The accompanying notes form an integral part of the standalone financial statements
Date: 05.01.2018 For and on behalf of the BoardPlace: Delhi
Sd/- Sd/- (Hema Gupta) (Sanjeev Goel)
Director DirectorDIN: 06673595 DIN: 00370189
AVENUE GEMS & JEWELS PRIVATE LIMITED
Unaudited Profit and loss statement for the period ended 31ST DECEMBER 2017CIN U52100DL2009PTC189939
1705/05,3rd Floor, Bhagirath Palace, North Delhi, Delhi-110006
P A R T I C U L A R S AS ON 31.12.2017 AS ON 31.3.2017
NOTE: 1Share Capital
Authorised Capital 1,00,000.00 1,00,000.00 10000 Equity Shares of Rs.10/ each 1,00,000.00 1,00,000.00
Issued Subscribed & Paid up Capital10000 Equity Shares Of Rs. 10/- Each Fully Paid 1,00,000.00 1,00,000.00
1,00,000.00 1,00,000.00
Details of shares held No of shares held No of shares held Sanjeev Goel HUF 6,000.00 6,000.00 Rajni Goel 4,000.00 4,000.00
10,000.00 10,000.00
NOTE: 2Reserves & Surplus - -
A - - Surplus (Profit /Loss)Balance brought forward from last year (28,999.00) (28,413.00) Add: Profit / (Loss) for the year 74,340.00 (586.00) Approrpiations - - Closing Balance B 45,341.00 (28,999.00) Total (A+ B) 45,341.00 (28,999.00)
NOTE: 3Long-term borrowingsUnsecured Loans - - From Companies - - From Directors & their relatives 64,000.00 54,000.00
64,000.00 54,000.00
NOTE: 4Other current liabilitiesExpenses Payable 4,560.00 10,000.00
4,560.00 10,000.00 NOTE: 5Short Term ProvisionsProv for Income Tax 25,781.00 -
25,781.00 -
For and on behalf of the Board
Sd/- Sd/- (Hema Gupta) (Sanjeev Goel) Director Director DIN: 06673595 DIN: 00370189
NOTES FORMING PART OF BALANCE SHEET AS ON 31st DECEMBER, 2017
AVENUE GEMS & JEWELS PRIVATE LIMITED
P A R T I C U L A R S AS ON 31.12.2017 AS ON 31.3.2017NOTE: 6Non- current investment(a) Investment Property (specify nature), (net off accumulated - - depreciation and impairement, if any)
(b) Investment in equity instruments (give details separately for fully/partly paid of instruments)
(i) of subsidiaries - - (ii) of associates 1,28,300.00 1,28,300.00 (iii) of joint venture companies - - (iv) of controlled special purpose entities - - (v) of other entities (give details) - -
1,28,300.00 1,28,300.00
NOTE: 7Trade Receivables(Unsecured Considered Good)Outstanding for a period exceeding six months - - Other Debtors 1,03,250.00 -
1,03,250.00 -
NOTE: 8Cash and cash equivalents(a) Cash in hand 1,382.00 6,701.00
1,382.00 6,701.00
NOTE: 9Other Current Assets(a) TDS 6,750.00 -
6,750.00 -
For and on behalf of the Board
Sd/- Sd/- (Hema Gupta) (Sanjeev Goel)
Director DirectorDIN: 06673595 DIN: 00370189
NOTES FORMING PART OF BALANCE SHEET AS ON 31st DECEMBER, 2017
AVENUE GEMS & JEWELS PRIVATE LIMITED
P A R T I C U L A R S
NOTE: 10Other IncomeOther Income 1,35,000.00 22,500.00
-
1,35,000.00 22,500.00 NOTE: 11Other ExpensesAudit Fees - 10,000.00 Accounting Charges 5,500.00 6,000.00 Filing Exp. 10,800.00 - General Exp. 2,365.00 4,672.00 Printing & Stationary 1,707.00 1,327.00 Travelling Exp. 1,905.00 1,087.00 Salary 8,000.00 - Conveyance Expenses 980.00 - Telephone Expenses 967.00 - Other Expenses 2,655.00 -
34,879.00 23,086.00
Sd/- Sd/- (Hema Gupta) (Sanjeev Goel)
Director DirectorDIN: 06673595 DIN: 00370189
For and on behalf of the Board
NOTES FORMING PART OF PROFIT AND LOSS ACCOUNT AS ON 31ST DECEMBER, 2017
AVENUE GEMS & JEWELS PRIVATE LIMITED
STERILE INDIA PRIVATE LIMITEDCIN: U74899DL1989PTC036517
Balance Sheet as at 31st December, 2017
Note As at No. 31st December 2017
(Rs.)
I. EQUITY AND LIABILITIES(1) Shareholders’ funds
Share Capital 1 154,488,800 Reserves and Surplus 2 1,141,906,509
1,296,395,309
(2) Non Current liabilitiesLong Term Provisions 3 5,145,518
5,145,518
(3) Current liabilitiesShort Term Borrowings 4 34,408,011 Trade Payables 5 653,469,707 Other Current Liabilities 6 58,205,046 Short Term Provisions 7 90,151,875
836,234,639
Total 2,137,775,466 II. ASSETS(1) Non-current assets
Property, plant and equipment 8 164,634,942 Intangible Assets 9 21,000 Non-current Investments 10 50,649,620 Deferred tax assets (Net) 11 (2,073,517) Long Term Loans & Advances 12 36,737,913 Other non-current assets 13 2,255,656
252,225,614
(2) Current assetsInventories 14 199,043,173 Trade Receivables 15 1,212,797,772 Cash and Bank Balances 16 245,521,630 Short Term Loans & Advances 17 222,727,690 Other Current Assets 18 5,459,587
1,885,549,852
Total 2,137,775,466
Notes to Financial Statements 1 to 28
The accompanying notes form an integral part of the Financial Statements
Sd/- Sd/- (SANJEEV GOEL) (RAJNI GOEL) Director Director
DIN: 00370189 DIN: 06487666
Place : DelhiDate : January 05, 2018
Particulars
For STERILE INDIA PRIVATE LIMITED
STERILE INDIA PRIVATE LIMITEDCIN: U74899DL1989PTC036517
Statement of Profit and Loss for the period ended 31st December, 2017
Particulars Note Period Ended No. 31st December 2017
(Rs.)
INCOMERevenue From Operations (Gross) 19 2,913,505,318 Less: Excise Duty 76,185,462 Revenue From Operations (Net) 2,837,319,856
Other Income 20 38,316,027 Total Revenue ( I ) 2,875,635,884
EXPENSESCost of Materials Consumed 21 2,232,366,392 (Increase)/Decrease in inventories of Finished Goods 22 (46,419,532) (Increase)/Decrease in inventories of Work-in-Progress 23 6,374,073 Employee Benefits Expense 24 38,868,637 Finance Costs 25 3,708,479 Depreciation & Amortization Expense 26 15,748,482 Other Expenses 27 220,273,909 Total expenses ( II ) 2,470,920,441
Profit/(Loss) Before Tax and prior period items ( I-II ) 404,715,443
Less: Tax Expense:(i) Current Tax 145,779,794 (ii) Deferred Tax Charge / (Credit) 2,487,701
148,267,495
Profit/(Loss) after tax but before prior period items 256,447,948
Profit/(Loss) for the period 256,447,948
Earnings Per Equity ShareBasic and Diluted 28 167.31
Notes to Financial Statements 1 to 28
The accompanying notes form an integral part of the Financial Statements
Sd/- (SANJEEV GOEL) Director
DIN: 00370189
Place : DelhiDate : January 05, 2018
For Sterile India Private Limited
DIN: 06487666
(RAJNI GOEL) Sd/-
Director
STERILE INDIA PRIVATE LIMITEDCIN: U74899DL1989PTC036517
Notes forming part of the Financial Statements for the Period Ended 31st December 2017
Particulars
NOTE - 1SHARE CAPITAL
No. of shares as at As at31st December 2017 31st Mar 2017 31st December 2017
Authorised share capital Equity shares of Rs. 100/- each 2,500,000 2,500,000 250,000,000
Issued, subscribed & paid up share capital Equity shares, fully paid up of Rs. 100/- eachIssued & paid up at the beginning of the period: 1,515,875 1,485,875 151,587,500
Add: Issued & paid up during the period: 29,013 30,000 2,901,300
Issued & paid up at the end of the period: 1,544,888 1,515,875 154,488,800
Details of shareholders holding more than 5% shares:
No. of Shares % heldSanjeev Goel 545,117 35.29 Bluestar Dealers Pvt. Ltd. 397,603 25.74 Rajni Goel 230,213 14.90 Vidya Sagar Aggarwal 211,560 13.69 Sanjeev Goel HUF 91,603 5.93
Terms / rights attached to the equity shares
NOTE - 2 As atRESERVES AND SURPLUS 31st December 2017Securities Premium Reserve
Opening Balance 404,989,500 Addition during the period 147,095,910 Closing Balance 552,085,410
As at31st December 2017Particulars
The Company has only one class of equity shares having a par value of Rs. 100/- per share. All the Equity Shares carry the same rights with respect to voting, dividends etc.
In the event of liquidation of the company, the holders of equity shares will be entitled to receive remaining assets of the company, after distribution of all preferential amounts. The distribution will be in proportion to the number of equity shares held by the shareholders.
STERILE INDIA PRIVATE LIMITEDCIN: U74899DL1989PTC036517
Notes forming part of the Financial Statements for the Period Ended 31st December 2017
Particulars
General ReserveOpening Balance 667,835 Addition during the period - Closing Balance 667,835
Surplus / (deficit) in the statement of profit & lossBalance as per last year 335,959,251 Add: Profit/ (Loss) after tax for period 256,447,948 Amount available for appropriation 592,407,199 Appropriations:Final equity dividend [Amount per share 1.75/- (F.Y 2016-17)] 2,703,554 Tax on equity dividend 550,381 Net surplus/ (deficit) 589,153,264
Total Reserves and Surplus 1,141,906,509
NOTE - 3 As atLONG TERM PROVISIONS 31st December 2017
Provision for retirement benefits 5,145,518 5,145,518
NOTE - 4 As atSHORT TERM BORROWINGS 31st December 2017Loans repayable on demand :
Secured Loans:From banks
Citi Bank - Cash Credit facility 18,408,011 Unsecured Loans:
From related parties or members 16,000,000
34,408,011
NOTE - 5 As atTRADE PAYABLES 31st December 2017Trade Payables
Total outstanding dues of micro and small enterprises - Total outstanding dues of creditors other than micro and small enterprises 653,469,707
653,469,707
STERILE INDIA PRIVATE LIMITEDCIN: U74899DL1989PTC036517
Notes forming part of the Financial Statements for the Period Ended 31st December 2017
Particulars
NOTE - 6 As atOTHER CURRENT LIABILITIES 31st December 2017
Interest accrued but not due on borrowings 555,657 Others Payables
Statutory Dues Payable 19,564,351 Expenses Payable 19,140,707 Advance from Customers 18,944,331
58,205,046
NOTE - 7 As atSHORT TERM PROVISIONS 31st December 2017Provision for retirement benefits 832,296 Others
Provision for Taxation 89,319,579 90,151,875
NOTE - 10 As atNON-CURRENT INVESTMENTS 31st December 2017Trade investment (valued at cost)Unquoted equity instruments (Fully Paid Up)
Sterile API Private Limited(25,01,000 (Previous Year: 1000) equity shares of Rs. 10/- each fully paid-up) 50,649,620
50,649,620
NOTE - 11 As atDEFERRED TAX ASSETS (NET) 31st December 2017Deferred Tax Assets on account of:
2,068,802 Less: Deferred Tax Liabilities on account of:
4,142,319 (2,073,517)
NOTE - 12 As atLONG TERM LOANS & ADVANCES 31st December 2017Unsecured, considered good
Capital advances 36,737,913 36,737,913
-- Impact of retirement benefits charged in the Statement of Profit & Loss in the current yearbut allowed for tax purpose on payment basis
-- Fixed Assets: Impact of difference between tax depreciation and depreciation charged forfinancial reporting
STERILE INDIA PRIVATE LIMITEDCIN: U74899DL1989PTC036517
Notes forming part of the Financial Statements for the period ended 31st December 2017
NOTE - 8PROPERTY, PLANT AND EQUIPMENT (Rs.)
Sr. No Particulars As on 01-04-2017
Addition during the period
Sales/ Adjustment during the period
As on 31-12-2017
As on 01-04-2017
During the period upto 31.12.2017
Adjustment during the period
As on 31-12-2017
As on 31-12-2017
Tangible Assets1 Land 62,368,563.00 - - 62,368,563 - - - - 62,368,563.00
2 Building 25,809,975.00 314,537.00 - 26,124,512 11,001,653.00 1,056,141.00 - 12,057,794.00 14,066,718.00
3 Plant and Machinery 112,993,563.00 8,261,364.00 - 121,254,927 41,295,149.00 9,741,860.00 - 51,037,009.00 70,217,918.00
4 Furniture and fittings 526,881.00 349,656.00 - 876,537 301,938.00 63,570.00 - 365,508.00 511,029.00
5 Motor Vehicles 18,136,760.00 60,000.00 - 18,196,760 5,259,104.00 3,042,125.00 - 8,301,229.00 9,895,531.00
6 Office Equipment 1,546,051.00 1,064,550.00 - 2,610,601 703,374.00 556,456.00 - 1,259,830.00 1,350,771.00
7 Computers and data processing units 1,351,031.00 194,745.00 - 1,545,776 1,007,824.00 186,366.82 - 1,194,190.82 351,585.18
8 Laboratory equipment 3,127,292.00 106,250 - 3,233,542 1,970,628 241,356 - 2,211,984 1,021,558.33
9 Electrical Installations and Equipment 7,260,320.00 1,266,723.17 - 8,527,043 4,721,440.00 597,850.00 - 5,319,290.00 3,207,753.17
10 Hydraulic works, pipelines and sluices 4,917,409.00 - - 4,917,409 3,021,636.00 252,258.00 - 3,273,894.00 1,643,515.00
TOTAL 238,037,845 11,617,825 - 249,655,670 69,282,746 15,737,982 - 85,020,728 164,634,942
Note -9
Intangible Assets (Rs.)
As of 01-04-2017
Addition during the period
Deduction during the period
As of 31-12-2017
As of 01-04-2017
Addition during the period
Adjusted during the period
As of 31-12-2017
1 System Software 52,500 - - 52,500 21,000 10,500 - 31,500 21,000
TOTAL 52,500 - - 52,500 21,000 10,500 - 31,500 21,000
Sd/- Sd/-(SANJEEV GOEL) (RAJNI GOEL)
Sd/- Director Director
(SANJEEV GOEL) DIN: 00370189 DIN: 06487666
Director DIN: 00370189
Carrying amount as on 31-12-2017Sr. No. Particulars
Gross Carrying Amount Accumulated Depreciation
For Sterile India Private Limited
Gross Block Depreciation
STERILE INDIA PRIVATE LIMITEDCIN: U74899DL1989PTC036517
Notes forming part of the Financial Statements for the Period Ended 31st December 2017
Particulars
NOTE - 13 As atOTHER NON-CURRENT ASSETS 31st December 2017Others
Fixed Deposit 2,255,656 2,255,656
NOTE - 14 As atINVENTORIES 31st December 2017
Raw Materials 87,675,440 Work-in-progress 267,125 Finished goods 111,100,609
199,043,173
NOTE - 15 As atTRADE RECEIVABLES 31st December 2017Unsecured, considered good
Debts outstanding for a period exceeding six months 312,672,074 Others 879,430,794
Unsecured, considered doubtfulDebts outstanding for a period exceeding six months 14,753,158 Others 31,016,951
1,237,872,977 Less: Provision for Bad and Doubtful Debts 25,075,205
1,212,797,772
NOTE - 16 As atCASH AND BANK BALANCES 31st December 2017Cash and Cash Equivalents
Cash in hand (as certified by the management) 2,432,718 Balance with Banks 42,067,999
Other Bank BalancesFixed Deposits 165,738,859 Recurring Deposit 35,282,054
245,521,630
STERILE INDIA PRIVATE LIMITEDCIN: U74899DL1989PTC036517
Notes forming part of the Financial Statements for the Period Ended 31st December 2017
Particulars
NOTE - 17 As atSHORT TERM LOANS & ADVANCES 31st December 2017Unsecured, considered good
Others:Advances recoverable in cash or in kind or for value to be received and/or adjusted- Suppliers 133,285,673 - Service Providers 53,517 - Employees 1,546,635 Security Deposit 9,929,768 Prepaid Expenses 259,620 Tax Credit 25,506,865
Unsecured loan 52,145,612 222,727,690
NOTE - 18 As atOTHER CURRENT ASSETS 31st December 2017
Interest accrued on Term Deposits 1,390,593 Interest accrued on Recurring Deposits 233,071 Interest accrued on Security Deposit 276,816 Others 3,559,107
5,459,587
NOTE - 19 Period EndedREVENUE FROM OPERATIONS (GROSS) 31st December 2017
Sale of Products - Domestic 2,452,139,482 Sale of Products - Exports 362,204,558
Sale of Products 2,814,344,039 Sale of Services 1,080,000 Other Operating Revenue 21,895,817
2,837,319,856
Total Sales revenue from sale of products (net of excise duty) 2,814,344,039 Excise duty 76,185,462 Total Sales Revenues ( Gross) 2,890,529,501
STERILE INDIA PRIVATE LIMITEDCIN: U74899DL1989PTC036517
Notes forming part of the Financial Statements for the Period Ended 31st December 2017
Particulars
Detail of Service rendered`Job Work 1,080,000
1,080,000
NOTE - 20 Period Ended OTHER INCOME 31st December 2017
Interest Income 12,872,537 Foreign Exchange Difference (Net) 24,440,139 Other Non-Operating Income 1,003,351
38,316,027
NOTE - 21 Period EndedCOST OF MATERIAL CONSUMED 31st December 2017
Inventories at the beginning of the year 118,339,460 Add: Purchases 2,201,702,371
2,320,041,831 Less: Inventories at the end of the year 87,675,440
Cost of Materials Consumed 2,232,366,392
NOTE - 22 Period Ended (INCREASE)/DECREASE IN INVENTORY OF FINISHED GOODS 31st December 2017
Inventories of Finished Goods at the end of the year: 111,100,609 Inventories of Finished Goods at the beginning of the year: 71,709,704 (Increase)/Decrease in Inventories of Finished Goods (39,390,905) Excise duty adjustment for movement in Finished Goods inventory (7,028,627) Net (Increase)/Decrease in Inventories of Finished Goods (46,419,532)
NOTE - 23 Period Ended(INCREASE)/DECREASE IN INVENTORY OF WORK IN PROGRESS 31st December 2017
Inventories of Work in Progress at the end of the year: 267,125 Inventories of Work in Progress at the beginning of the year: 6,641,198 (Increase)/Decrease in Inventories of Work in Progress 6,374,073
a
STERILE INDIA PRIVATE LIMITEDCIN: U74899DL1989PTC036517
Notes forming part of the Financial Statements for the Period Ended 31st December 2017
Particulars
NOTE - 24 Period EndedEMPLOYEE BENEFITS EXPENSE 31st December 2017
Salaries & Wages 34,701,916 Contribution to Provident and Other funds
Employer's Contribution to PF & ESI 823,302 Employer's Contribution to Labour Welfare Fund 31,160 Retirement Benefits 1,122,402
Staff Welfare Expenses 2,189,857 38,868,637
NOTE - 25 Period EndedFINANCE COST 31st December 2017
Interest Expense 3,708,479 3,708,479
NOTE - 26 Period EndedDEPRECIATION AND AMORTIZATION EXPENSE 31st December 2017
Depreciation on tangible assets 15,737,982 Amortization of intangible assets 10,500
15,748,482
NOTE - 27 Period EndedOTHER EXPENSES 31st December 2017
Power & Fuel 73,677,902 Repair & Maintenance Expenses - Plant & Machinery 10,575,809 Consumption of stores and spares parts 6,660,555 Research and Development Expenses 14,784,915 Repair & Maintenance Expenses - Building 3,928,275 Commission on Sales 18,875,188 Rent 12,763,334 Business Promotion 16,617,251 Bank Charges 1,332,991 Insurance Expenses 3,492,939 Export Freight 3,444,987 Legal & Professional Charges 1,601,685
STERILE INDIA PRIVATE LIMITEDCIN: U74899DL1989PTC036517
Notes forming part of the Financial Statements for the Period Ended 31st December 2017
ParticularsTour & Travelling Expenses 1,229,141 Miscellaneous Expenses 50,613,936 Payments to Auditor : - for Audit Fee 675,000
220,273,909
NOTE - 28 Period EndedEARNINGS PER SHARE 31st December 2017
Net Profit/(Loss) attributable to Equity Shareholders (Rs.) 256,447,948 Weighted Average Number of Equity Shares 1,532,755 Basic and Diluted Earnings Per Share (Rs.) 167.31 Nominal Value Per Share (Rs.) 100.00
For STERILE INDIA PRIVATE LIMITED
Sd/- (SANJEEV GOEL) (RAJNI GOEL) Director Director
DIN: 00370189 DIN: 06487666
Sd/-
BEFORE THE NATIONAL COMPANY LAW TRIBUNAL
NEW DELHI BENCH, NEW DELHI
(ORIGINAL JURISDICTION)
COMPANY APPLICATION NO. CA (CAA) 22 (ND) OF 2018
IN THE MATTER OF THE COMPANIES ACT, 2013 (18 OF 2013)
SECTIONS 230 & 232
AND
IN THE MATTER OF SCHEME OF AMALGAMATION
AND
IN THE MATTER OF
STERILE API PVT LTD APPLICANT/ TRANSFEROR COMPANY NO. 1
BLUESTAR DEALERS PVT LTD
APPLICANT/ TRANSFEROR COMPANY NO. 2
SACH TECHNOLOGY PVT LTD
APPLICANT/ TRANSFEROR COMPANY NO. 3
AVENUE GEMS & JEWELS PVT LTD APPLICANT/ TRANSFEROR COMPANY NO. 4
AND
STERILE INDIA PVT LTD APPLICANT/TRANSFEREE COMPANY
FORM OF PROXY
I/We, the undersigned, Un-secured Creditor(s) of Sterile API Pvt Ltd, hereby appoint Mr/Ms ___________________ of _____________________
and failing him/her, Mr/Ms ___________________ of ____________________ as my/our proxy to act for me/us at the meeting of the Un-secured Creditors
of Sterile API Pvt Ltd scheduled to be held on Saturday, 28th April, 2018, at 10.30 a.m. at Hotel City Park, KP Block, Gopal Mandir Road, Pitampura, New Delhi-110 088 for the purpose of considering and, if thought
fit, approving, with or without modification, the proposed Scheme of Amalgamation of Sterile API Pvt Ltd, Bluestar Dealers Pvt Ltd, Sach Technology
Pvt Ltd and Avenue Gems & Jewels Pvt Ltd with Sterile India Pvt Ltd, and at such meeting and at any adjournment thereof, to vote, for me/us and in my/our
name ________________ the said Scheme either with or without modification as my/our Proxy may approve.
# If you want to vote in favour of the Scheme put “FOR” and in case you intend to vote against the Scheme put “AGAINST” and in the latter case, strike out
all the words after the words “the said Scheme”
Dated this _______ day of ____________, 2018
Name: ________________________
Address: ______________________
______________________________
______________________________
Affix Re. 1.00
Revenue Stamp
Signature(s) across the Stamp
Notes:
1. Please affix revenue stamp and sign across the stamp.
2. The Proxy must be deposited at the registered office of the Company not later than 48 hours before the time fixed for convening the meeting.
3. All the alterations, made in the Proxy Form, must be initialed.
4. Proxy need not be a member/creditor of the Applicant Company.
Sterile API Pvt Ltd
[CIN: U 17121 DL 2007 PTC 168198]
Registered Office: 1705, 4th Floor, Onkar Bhawan, Bhagirath Palace, Chandni Chowk, Delh-110 006
E-mail: [email protected]
Attendance Slip
Sl. No.
Ref. No.
Name of Un-secured
Creditor(s)
Name of Proxy/ Authorized Rep., if any
I hereby record my presence at the meeting of the Un-secured
Creditors of Sterile API Pvt Ltd being held on Saturday, 28th April, 2018,
at 10.30 A.M. at Hotel City Park, KP Block, Gopal Mandir Road, Pitampura,
New Delhi-110 088, under the supervision of the National Company Law
Tribunal, New Delhi Bench, New Delhi, for the purpose of considering and, if
thought fit, approving, with or without modification, the Scheme of
Amalgamation of Sterile API Pvt Ltd, Bluestar Dealers Pvt Ltd, Sach
Technology Pvt Ltd and Avenue Gems & Jewels Pvt Ltd with Sterile India Pvt
Ltd, and other connected matters, if any.
Signature